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Abstract
Putative Glucosyltransferase 11 from Citrus paradisi:
Cloning, Recombinant Expression in Yeast, and Substrate Screening
by
Bruce E. Williams
Plant secondary products, which include the flavonoids, have a variety of roles in plant
systems. Their roles include UV protection, antifeedant activity, pollinator attraction, stress
response, and many others. Flavonoids also have effects on human physiology. Glucosylation is
an important modification of many flavonoids and other plant secondary products. In grapefruit,
glucosylation is important in the synthesis of the bitter compound naringin. Glucosyltransferases
catalyze glucosylation reactions. Putative plant secondary product glucosyltransferases may be
identified by the loosely conserved “PSPG box” amino acid sequence, and eleven have been
isolated to date in Citrus paradisi. With current knowledge, however, biochemical
characterization is the only way to determine with certainty the function of these enzymes. The
hypothesis tested here is that PGT11 is a plant secondary product glucosyltransferase. To
investigate the hypothesis, recombinant PGT11 (rPGT11) was expressed in yeast using the
pPICZ A vector, and the enzyme was screened for glucosylation activity with flavonoid
substrates of the flavanone, flavone, flavonol, and isoflavone subclasses. No significant activity
was detected with any of the substrates screened; however, the tests should be repeated for
verification. Flavonoids of other subclasses, phenolic acids, and other phenolics could be tested
as well.
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1. Introduction
1.1 – Flavonoids: some of their roles in plants and effects in humans
Flavonoids arise from the phenylpropanoid pathway and are derived from the amino acid
phenylalanine and malonyl-CoA (Winkel-Shirley 2001). Chalcones are the earliest in flavonoid
biosynthesis; flavanones, flavones, flavonols, and other flavonoids are derived from chalcones
(Winkel-Shirley 2001, Figure 1).

Naringenin chalcone (Chalcone)
CHI

IFS

FSI

Naringenin (Flavanone)

Isoflavone

Flavone

F3H

FLS

Flavonol

DFR

Dihydroflavonol

Leucocyanidin
ANS

Figure 1. The flavonoid biosynthetic pathway (adapted from Heller
and Forkmann 1988, Wamucho 2012). CHI: chalcone isomerase.
IFS: isoflavone synthase. FSI: flavone synthase.
F3H: flavanone 3β hydroxylase. DFR: dihydroflavonol 4-reductase.
FLS: flavonol synthase. ANS: anthocyanidin synthase.
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Anthocyanidin

Flavonoids are broadly distributed phenolic compounds in higher plants, and over 6000
have been identified (Harbourne 1994 and ref. therein, Veitch and Grayer 2008 and ref. therein).
A given plant, however, contains a smaller subset of these compounds. For example, of nine
flavonoid subclasses, the most abundant in grapefruit are the flavanones, flavones, and flavonols;
other subclasses are fewer or absent (Berhow et al 1998, McIntosh and Mansell 1990, Owens
and McIntosh 2011).
Flavonoids have numerous roles in plants. For example, flavonoids are important for
pollination of flowers. Flavonol aglycones are important regulators of pollen germination (Mo et
al 1992). Flavonoid pigments, such as glycosides of delphinidin and cyanidin, attract pollinators
to flowers (Harbourne and Grayer 1993 and ref. therein). For example, Waser and Price (1983)
found that the anthocyanin pigments in the petals of Delphinium nelsonii provide an important
visual stimulus for bee and hummingbird pollinators; white flowers had a much longer handling
time, possibly because pollinators have difficulty in locating nectar reserves without the
contrasting pigments of wild-type Delphinium flowers.
Flavonoids also figure in other types of plant-insect interactions. For instance, the
flavonol quercetin 3-O-glucoside in mulberry leaves stimulates biting in the silkworm Bombyx
mori (Hamamura et al 1962). Other flavonoids of the flavonol, flavone, flavanone,
dihydroflavonol, and dihydrochalcone subclasses are also known to act as feeding stimulants or
inhibitors; some flavonoids may stimulate feeding in one insect while inhibiting it in another
(Harbourne and Grayer 1993 and ref. therein).
There is evidence that select flavonoids protect plants and their photosynthetic
components from UV-B radiation damage. One study (Ormrod et al 1995) showed that mutant
Arabidopsis thaliana lacking flavonoids in epidermal tissue were very sensitive to UV-B
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radiation. Stapleton and Walbot (1994) found that purple-leaved maize (with anthocyanin
pigments) suffered less DNA damage than green-leaved maize. These studies are reviewed in
Harbourne and Williams (2000).
Many properties of flavonoids make them useful or of interest to humans. In Citrus,
flavonoids initially garnered interest because of their effect on the taste and color of fruit (Owens
and McIntosh 2011 and ref. therein). Naringin and other compounds in grapefruit and grapefruit
juice can interact with various anti-cancer, anti-infectives, anti-inflammatory agents, cholesterol
medications, and other drugs (Bailey et al 2013). Much of this interaction is due to inhibition of
cytochrome P450 3A4, which is necessary for metabolism of a broad range of compounds
(Bailey et al 1998). Properties such as antifungal and antibacterial activity could make flavonoids
useful to humans. Salas et al (2011) showed that the flavanones prunin, hesperetin,
neohesperetin, naringin, and some synthetically-modified derivatives of these compounds
inhibited the growth of the fungi Fusarium semitectum, Penicillium expansum, Aspergillus
parasiticus, and Aspergillus flavus. Another study (Mori et al 1987) demonstrated that datiscetin
and quercetagetin inhibited Gram-negative Proteus vulgaris, and 7,8-dihyrdroxyflavanone
inhibited Gram-positive Staphylococcus aureus; robinetin, myricetin, (+)-dihydrobinetin, and
(-)-epigallocatechin acted against both S. aureus and P. vulgaris. For more information on
antimicrobial flavonoids see the review by Cushnie and Lamb (2005).
Flavonoids have cardiovascular effects. One study showed that, of seventeen flavonoid
compounds tested, the flavones apigenin and luteolin produced the greatest relaxation of porcine
arteries in vitro (Xu et al 2007). Dietary flavonoids may reduce rates of coronary heart disease
mortality (Harbourne and Williams 2000 and ref. therein). Hertog et al (1993), for example,
found that flavonoid intake in 805 elderly men was correlated with a decreased incidence of
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heart attack and death from heart disease. Frankel et al (1993) showed that, in vitro, mixed
phenolics extracted from red wine, which include flavonols and anthocyanins (glucosides of
anthocyanidins), decreased the copper-catalyzed oxidation of human low-density lipoprotein
(LDL) and may help prevent atherosclerosis in vivo. In a second in vitro study, the same group
measured the antioxidant effects of individual phenolics and some phenolic mixtures from red
wine and red grapes on human LDL; among the compounds with the highest inhibition of LDL
oxidation were catechin, myricetin, epicatechin, and rutin (Teissedre et al 1996).
Additionally, select flavonoids have shown cytotoxic effects against several types of
human cancers in vitro, such as leukemia (Makino and Fujimoto 1999). Two benzyl
dihydroflavonols from Baeckea frutescens were active against leukemia, skin, renal, and colon
cancer cell lines (Lee et al 1996). Silva et al (1995) found that the flavones 4’, 7”-di-Omethylamentoflavone and 7”-O-methylrobustaflavone were active against cancers of several
types, including those of the breast, lung, colon, skin and prostate. Coghlan (1998) showed that
genistein, an isoflavone from soy inhibits growth and angiogenesis of cancer cells, while leaving
normal cells unharmed. For more information on anti-cancer effects of flavonoids, see the
review by Harbourne and Williams (2000).

1.2 – Glucosyltransferases (GTs)
Glucosyltransferases (GTs) are enzymes that catalyze the transfer a glucose group from a
donor substrate to an acceptor substrate. Attachment of glucose groups (glucosylation) can
stabilize molecules, affect molecules’ water-solubility and transportability within the plant, and
affect availability of molecules for other biochemical processes (Vogt and Jones 2000 and ref.
therein). Across all species, thousands of putative GT sequences have been identified (Vaistij et
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al 2009); however, only about forty plant secondary product glucosyltransferases have been
biochemically characterized (McIntosh, personal communication). Plant glucosyltransferases
share a 44-amino acid consensus sequence known as the PSPG box; this motif is known to
contain the binding site for sugar donor substrates such as UDP-glucose (Vogt and Jones 2000,
Offen et al 2006). While putative glucosyltransferases may be identified by the presence of this
motif, function cannot be reliably predicted based on sequence alone. For example, two
glucosyltransferases from Dorotheanthus bellidiformis with only 20% identity, UGT73A5 and
UGT71F2, transfer glucose to the same acceptors (Osmani et al 2009 and ref. therein, Vogt
2002, Vogt et al 1997, and Vogt et al 1999). Glucosyltransferases with high identity can act upon
different sets of substrates (Osmani et al 2009 and ref. therin).

1.3 – Studying plant GTs
Our lab uses the grapefruit (Citrus paradisi, cv. Duncan) as a model system for studying
flavonoid GTs. Grapefruit is a suitable model, because it has a wide variety of flavonoids, most
of which are glucosylated derivatives known as flavonoid glucosides (Owens and McIntosh
2011). In addition, chalcone, flavanone, and flavonol GT activities of enzymes isolated from
grapefruit leaf tissue have been reported (McIntosh et al 1990). An enzyme purified from
grapefruit tissue by McIntosh et al (1990) glucosylates the 7-hydroxyl position of the flavanone
naringenin to form prunin. Subsequent rhamnosylation of C-2 of the glucose of prunin forms the
diglycoside naringin, which comprises between 40 and 70 percent of the dry weight of young
fruit tissues (Jourdan et al 1985, McIntosh and Mansell 1990). The bitter taste of naringin and
other neohesperidosides arises from the O-linkage of C-1 of rhamnose to C-2 of glucose;
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rutinosides, in which rhamnose is bound to glucose in a 1 à 6 O-linkage, are tasteless (Owens
and McIntosh 2011 and ref. therein, Figure 2).

2
1

1-2 RT
Naringin (bitter)

1-6 RT

Flavanone
7GT
Naringenin
(aglycone)

1

6

Prunin
(naringenin 7-O-glucoside)

Narirutin (tasteless)

Figure 2. Biosynthesis of naringin and narirutin in Citrus (adapted from Owens and
McIntosh 2011). Flavanone 7GT: flavanone 7-O-glucosyltransferase. 1-2 RT and 1-6 RT: 1-2
rhamnosyltranferase (links C-1 of rhamnose to C-2 of glucose) and 1-6 rhamnosyltranferase (links
C-1 of rhamnose to C-6 of glucose), respectively.
Due to low concentrations of GTs in grapefruit tissue, purifying the enzymes directly
from plant sources is problematic. Cloning grapefruit GTs into expression vectors to produce
recombinant enzyme in Escherichia coli and Pichia pastoris has been useful in production of
protein in amounts sufficient for study (e.g., Owens and McIntosh 2009, Mallampalli 2009, Lin
2011, Wamucho 2012, and Hayford 2012). Cloning and biochemical characterization of
recombinant putative GTs also allow for study of structure-function relationships.
Our lab has identified eleven putative glucosyltransferases (PGTs). These were identified
as PGTs based on the presence of the PSPG box. Several of our PGTs have been expressed in E.
coli to determine the activity of the recombinant proteins; however, E. coli often package the
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proteins into insoluble masses called inclusion bodies (e.g., Owens and McIntosh 2009,
Mallampalli 2009, Ford et al 1998). When most of the protein of interest is in inclusion bodies,
obtaining enough soluble protein to test for activity is difficult. In some cases, enough soluble
protein is produced when culture conditions are optimized; however, alternate expression
systems such as P. pastoris are needed to study some PGTs (Owens and McIntosh 2011).
Of eleven PGTs, PGT7 was shown to be a flavonol 3-O-glucosyltransferase (Owens and
McIntosh 2009), and PGT 8 is 98% identical to a Citrus unshiu glucosyltransferase that
glucosylates limonoids, a class of triterpenoids (Owens and McIntosh 2011 and ref. therein,
Hayford 2012). Preliminary results for PGTs 3 and 9 show some activity with non-flavonoid
phenolics (Wamucho 2012, Hayford 2012). Daniel et al (2011) showed that mRNA expression
levels of these PGTs in Duncan grapefruit vary with tissue and maturity.

1.4 – Previous work with PGT11
In previous work, Mallampalli (2009) mined the PGT11 contig from the harvEST
bioinformatic database (see Figure 3 at the end of this chapter), PCR-amplified the sequence
from young grapefruit leaf cDNA, and cloned it into the pCR®4-TOPO vector. Subsequently,
Wamucho (2012) cloned PGT11 into the pPICZ A vector for expression in yeast. PGT11 from
the harvEST database has over 80% identity and 90% similarity at the amino acid level to an
uncharacterized and recently posted gene (orange1.1g012744m) in Citrus sinensis
(www.phytozome.net).
Wamucho (2012) designed primers to amplify PGT11 from the pCR®4-TOPO vector
with modified ends. Wamucho added to the 5’ end of PGT11 a KpnI restriction site and a yeast
consensus sequence of the form (G/A)NNATGG, where ATG is the start codon. Such a sequence
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can increase the efficiency of translation initiation in Pichia pastoris by 2 to 3 fold (Life
Technologies 2011). The PGT11 sequence was such that the native start codon could not be used
in the yeast consensus sequence, and it was necessary to add two amino acids at the N-terminal
of the protein (Wamucho 2012). At the 3’ end of PGT11, a SacII restriction site was added and
the native stop codon removed to facilitate recombinant expression with a C-terminal c-myc
epitope (detection) and polyhistidine (purification) fusion tag (Wamucho 2012).

1.5 – Hypothesis
In this work, recombinant PGT11 was expressed in the yeast Pichia pastoris (strain X33) using the pPICZ A expression vector. The hypothesis tested here was that PGT11 is a plant
secondary product GT and, specifically, a flavonoid GT. The ultimate goal of this research was
to fully characterize the function of PGT11.

8

A

B

ATGAGCAGTC
CTAGAGTTGT
TATAATCACA
CATCTGGTGT
TTGTTAGAAA
CATGGAAGAG
ATTGAAGTCG
ACAGTGGCCT
GGGACTCCAA
GGAGAGCTAT
ATGGTGCAAA
GAGCTGGAGG
GCGAGCAACC
GAATGGCTAG
GTACTCGAGC
TTCTTATGGG
TTTCGAGAGA
CTCACCCACC
GGTGTGAGCA
ACCACCTACA
ATTATCGGAA
AAGGCAAGGG
TCCAACAAGG

CCCATGTTGT
CACAAAATTT
ATCGGGTATT
CGATCCCTGA
AACGTTTACA
GAGGTGAAAA
CTGAGAAGAT
TGACATTCAG
TCAAGGAACA
TTTGGACTCG
ACATGAGAGC
GTGGAGCATT
GGTTAGGAAA
ACCAACAGCA
AAAATCAGTT
TGGTGAGGCC
GAGTAGCCGC
CTTCCATTTC
ACGGAGTCCC
TTTGTGATGT
GAGAAGAAAT
CCTTAAAGCT
CAATTCAGAA

GGTAATACCG
GGCCAAGCAT
GGAATCATTA
TGGAATCGAA
GGTTATGCCT
AATAGCTTGT
GAAACTCAGG
TATCCCTAAG
AATGATTCAA
CTTTGGTGAC
GACGAGAGCG
CAGTATGATT
TTCAGCAGGA
AGCAAACTCA
CCAAGAATTA
AGATATTACC
TCGAGGACAG
CTGTTTCATG
TTTCCTGTGT
TTGGAAGGTG
TAAGAACAAG
TAAGGAAAAA
TTTCGTTCAA

AATCCAGAAC
GGCCTGAGAA
GAAGGAAAGA
CCATGGGATG
GGAAAGCTGG
CTCATTGCAG
CGGGCGGTTG
CTGATAGAGG
TTGGCACCAA
TTGACCATGC
GTAGATTTCC
CCGGAGCTTC
TACTTTTTGC
GTCATTTATG
GCATTAGGAC
AATGATGCAA
ATGATCAGTT
AGCCACTGCG
TGGCCATTCT
GGATTGAGGC
GTGGATCAAG
GCCCTCAGTA
TCCATCAAGC

AAGGGCATGT
TCACATTTGT
ATTACATTGG
ACAGGAGTGA
AGGGGCTCAT
ATGGGGCAGC
TAGTGATAAC
ATGGGGTCAT
ATATGCCTGC
AAAAAATCTT
AGTTATGCAA
TTCCAATAGG
CAGAAGACTC
TTGCTCTGGG
TTGAAATCTG
ATGATGCATA
GGTCTCCTCA
GTTGGAATTC
TTGCTGACCA
TTGAAAGAAA
TGCTGGGTGA
GTGTCAGAGA
AATGGCCCGC

AATTCCTTTA
GAACTCGGAG
GGAGCAAATC
TATGAGAAAG
AGAAGAGATC
GGGGTGGGCT
CTCAGCAGCA
TAACAGTAAC
AATAAGCACT
CTTTGATTTT
CTCAACATAC
ACCACTTTTG
AAAATGTGTG
GAGCCACACG
CAACAGAGCG
CCCTGAAGGA
GCAGAAGTTT
CACCACGGAA
ATTCATGAAC
CCAAAGTGGT
TCAAAATTTT
AGGTGGTTCA
ATGA

MSSPHVVVIP
HLVSIPDGIE
IEVAEKMKLR
GELFWTRFGD
ASNRLGNSAG
FLWVVRPDIT
GVSNGVPFLC
KARALKLKEK

NPEQGHVIPL
PWDDRSDMRK
RAVVVITSAA
LTMQKIFFDF
YFLPEDSKCV
NDANDAYPEG
WPFFADQFMN
ALSSVREGGS

LELSQNLAKH
LLEKRLQVMP
TVALTFSIPK
MVQNMRATRA
EWLDQQQANS
FRERVAARGQ
TTYICDVWKV
SNKAIQNFVQ

GLRITFVNSE
GKLEGLIEEI
LIEDGVINSN
VDFQLCNSTY
VIYVALGSHT
MISWSPQQKF
GLRLERNQSG
SIKQWPA

YNHNRVLESL
HGRGGEKIAC
GTPIKEQMIQ
ELEGGAFSMI
VLEQNQFQEL
LTHPSISCFM
IIGREEIKNK

EGKNYIGEQI
LIADGAAGWA
LAPNMPAIST
PELLPIGPLL
ALGLEICNRA
SHCGWNSTTE
VDQVLGDQNF

Figure 3. PGT11 contig sequence from the harvEST database (Mallampalli 2009).
A: contig sequence (1374bp).
B: amino acid translation of contig sequence (457aa).
Color code (B only): Blue = positively charged side-group. Red = negatively charged side
group. Gray = Polar but uncharged. Green = hydrophobic side group. Gold = hydrogen
side group. Purple = proline, cyclic structure (can force bends).
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2. Experimental
2.1 – Extraction of PGT11 D-pPICZ A Plasmid DNA from Escherichia coli by Midiprep
TOP10 E. coli (Invitrogen) containing PGT11 D-pPICZ A DNA (from Anye Wamucho’s
colony D) (Wamucho 2012) were inoculated into 100 mL of Low Salt LBZeocin (25 mg/L) (Appendix
A). The culture was grown for 16 hours in a New Brunswick I 24 incubator shaker at 37 °C, 250
rpm. A culture of E. coli containing empty pPICZ A vector was prepared in the same manner.
Plasmid DNA was extracted from two 50-mL aliquots of each culture using a Quantum Prep™
Plasmid Midiprep Kit (Bio-Rad). The midiprep was carried out according to manufacturer’s
instructions; however, 30-second microcentrifugation steps were lengthened to 60 seconds to
ensure that fluids were completely drained from the spin column.
The plasmid DNA was eluted in 600 μl of sterile dH2O; however, because a small (1.5mL) microfuge tube was used, not all of the 600 μL was eluted from the spin column on the first
spin. Another 300 μL of dH2O was added to each spin column and the additional elution was
collected in a fresh 1.5-mL microcentrifuge tube. The DNA concentration of each midiprep
sample was measured using a Nanodrop-1000 spectrophotometer, its accompanying software
(v3.5.2), and a 2-μL aliquot of each sample (Table 1 below).
Concentration (ng/μL)
DNA
Total DNA in sample (μg)
PA 1.I
57.1
30.0
PA 1.II
30.2
11.3
PA 2.I
53.8
29.9
PA 2.II
26.2
9.0
PG 1.I
115.4
60.6
PG 1.II
51.1
19.2
PG 2.I
131.9
66.0
20.8
PG 2.II
52.0
“PG” samples are PGT11 in pPICZ A vector. “PA” samples are empty pPICZ A vector.
Samples with Roman numeral II are from second elutions from the spin columns.
Table 1. Concentrations of pPICZ A and PGT11-pPICZ A Plasmid DNA extracted from
Wamucho’s (2012) E. coli colony D.
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To visualize the plasmid DNA, a 1-μL aliquot of the initial elutions and a 2-μL aliquot of
the latter elutions were mixed with dH2O to a volume of 5 μL. The 5-μL samples were mixed
with 1μL of blue/orange 6x loading dye (Promega) and were run for 45 min at 100 V on agarose
(0.8 %) gel. The agarose gel was prepared in this manner: A 0.24-g portion of agarose powder
(Fisher Scientific) was weighed into an Erlenmeyer flask. Then, TAE buffer (Appendix B) was
added to a mass of 30g. The flask was then microwaved for 1 min 50 sec to dissolve the agarose
in the TAE buffer. The flask was swirled smoothly to mix any remaining un-dissolved agarose
and microwaved for an additional 30 seconds. After swirling again to mix and allowing the flask
to cool for 1 minute, the flask was returned to the top-loading balance on which the agarose and
TAE buffer had been weighed. To compensate for water evaporated during microwaving, dH2O
was added until the mass of the agarose and TAE had returned to 30 g. The gel was stained
before solidification by adding 2 μL of ethidium bromide (10 mg/mL) (prepared from ethidium
bromide powder (Fisher Scientific)) which was swirled to mix. An additional 15 μL of ethidium
bromide solution was added to the TAE running buffer and was mixed by stirring with a pipette
tip.

2.2 - Linearization of PGT11 D-pPICZ A plasmid
Before the PGT11-pPICZ A construct could be moved into yeast for expression of
recombinant PGT11, it had to be linearized. The expression vector manufacturer’s manual (Life
Technologies 2011) states that non-linearized plasmid may be transformed into P. pastoris;
however, this requires 50 to 100 μg of plasmid DNA, whereas only 5 to 10 μg of linearized
plasmid is required (Life Technologies 2011). The construct was linearized as recommended by
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the pPICZ A vector manufacturer by cleavage at a single SacI restriction site within the AOX1
promoter region.
Two digestions each were performed for pPICZ A and PGT11-pPICZ A plasmid DNA
using samples PA 1.II, PA 2.II, PG 1.II, and PG 2.II from Table 1 above. Four microcentrifuge
tubes were prepared as in Table 2 below, adding the restriction enzyme SacI (Promega) last.

Tube
PA 1.II
PA 2.II
PG 1.II
PG 2.II

Plasmid DNA
(μL)
375
345
375
400

10X Buffer J
(μL)
42.6
39.2
42.6
45.4

100X BSA
(μL)
4.26
3.92
4.26
4.54

SacI
(μL)
4
4
4
4

Table 2. SacI RE digestion reaction mixtures for linearization of PGT11 D-pPICZ A. The 100X BSA and 10X
Buffer J solutions were purchased from Promega.

The contents of each reaction were gently mixed by pipetting, then centrifuged for 20
seconds in a tabletop centrifuge at 10 000 rpm. The digestions were incubated for 2 hours in a
37°C water bath, after which 4 μL more SacI enzyme was added to each reaction. The samples
were mixed and centrifuged as before and returned to the 37°C water bath for an additional two
hours. To check the progress of the reactions, a 2-μL aliquot of each reaction mixture was run on
an agarose (0.8%) gel as previously described. Three of the reactions appeared complete and
were stopped by incubating them for 5 minutes at 65°C to denature SacI. The fourth reaction,
PG2, was incomplete. An additional 4 μL of SacI (Promega) and 4.5 μL of 100X acylated BSA
(Promega) was added to this sample, and it was mixed and centrifuged as before. The reaction
was then returned to the 37°C water bath to incubate overnight (approximately 10 hours). The
following morning, 4 μL more enzyme was added to the reaction, and the reaction was incubated
for an additional four more hours after mixing and centrifuging as before. A 2-μL aliquot of the
12

reaction was run as before on an agarose (0.8%) gel alongside 2-μL aliquots of the previously
stopped reactions. The reaction was deemed complete.

2.3 – Purification and concentration of linearized plasmid DNA
(phenol-chloroform extraction and ethanol precipitation)
To each digestion (linearization) reaction mixture was added an equal volume of phenol:
chloroform: isoamyl alcohol (25:24:1) (Fisher Scientific). Each sample was then vortexed
vigorously and microcentrifuged for 1 minute at 13 000 rpm. The top (aqueous) phase was drawn
out of each tube and transferred to a fresh tube, and 1/10 volume of sterile (autoclaved) 3 M
sodium acetate (granular sodium acetate from Fisher Scientfic) was added to each, followed by
2.5 volumes of ice-cold 100% ethanol. The four samples were then vortexed for 3 to 5 seconds
and incubated for 30 minutes in a -20°C freezer.
At the end of the incubation, the samples were microcentrifuged at 15 000 rpm, 4°C for
15 minutes. The supernatant was carefully decanted and each DNA pellet was gently rinsed (not
re-suspended) with 250 μL of ice-cold 80% ethanol to remove salts from the precipitate. The
samples were then centrifuged at 15 000 rpm, 4°C for 10 min. The supernatant was carefully
decanted, and the pellets were dried by inverting the tubes for 15 minutes at room temperature on
a double layer of Kimwipes (Kimberly-Clark). Each pellet was re-suspended in 10 μL of sterile
dH2O. A 1:20 dilution was made of each concentrated, linearized plasmid DNA solution, and 1and 2-μL aliquots of each 1:20 dilution were run alongside 10 μL of exACTGene 1 kb plus DNA
ladder on an agarose (0.8%) gel as described previously.
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2.4 – Transformation of linearized PGT11 D–pPICZ A plasmid into Pichia pastoris
P. pastoris (X-33) was inoculated from glycerol stock into 5 mL of YPD medium
(Appendix A) and incubated for approximately 24 hours in a New Brunswick I 22 Incubator
Shaker at 30 °C, 250 rpm. A 100-μL portion of this culture was used to inoculate 100 mL of
fresh YPD medium, and this larger culture was grown for approximately 15 hours at 30°C, 250
rpm to A600 = 1.4. An A600 in the range of 1.3 to 1.5 indicates that the yeast are in the proper
growth phase to be used for electroporation.
The yeast cells were harvested by centrifuging the 100-mL culture at 1500 x g for 5 min
at 4°C. The supernatant was poured off and the pellet was re-suspended in 250 mL of ice-cold
sterile dH2O to wash away the YPD media. The cells were then centrifuged as previously
described and the supernatant was again discarded. Next, the cells were washed again by
resuspending them in 150 mL of sterile dH2O. The cells were centrifuged again as previously
described, the supernatant discarded, and the pellet re-suspended in 10 mL of sterile, ice-cold
1 M sorbitol. The cells were centrifuged a final time, the supernatant discarded and the cells resuspended in 700 μL of sterile, ice-cold 1 M sorbitol for a final volume of approximately 1 mL.
(Note: The yeast should have been re-suspended in a smaller volume of 1 M sorbitol. The Pichia
Easy Select user’s manual (Life Technologies 2011) suggests that yeast from a 500-mL culture
be re-suspended in 1 mL of 1M sorbitol. Thus, the procedure was not properly scaled down.) The
1 M sorbitol maintains an isotonic environment for the yeast cells during the electroporation
procedure and prevents them from lysing. This suspension of yeast in 1M sorbitol was
transferred to a sterile 1.5-mL microcentrifuge tube and kept on ice until the electroporation
approximately 2 hours later.
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An 80-μL portion of the yeast suspension was mixed with 9 μL of linearized,
concentrated PGT11 D-pPICZ A DNA, and the mixture was transferred to an electroporation
cuvette on ice. (Note: The concentrataion of the linearized plasmid was determined to be greater
than 0.86 μg/μL by electrophoresis of 1 μl of a 1:20 dilution alongside quantitative standards;
however, the exact concentration was not determined. See results section Figure 3 for image of
agarose gel.) The cuvette was incubated on ice an additional five minutes, after which it was
pulsed at 1.50 kV on manual setting in a Bio-Rad MicroPulser™ electroporation device.
Immediately after pulsing, 1mL of ice-cold, sterile 1 M sorbitol was added to the cuvette. Next,
the entire content of the cuvette was transferred to a sterile, 15-mL glass tube and incubated at
30°C for 90 min without shaking. Following the incubation, 50 μL of cells were plated on
YPDSZeocin (100mg/L) (Appendix A). On another plate, 100 μL of cells were plated. The remaining
cells were stored at 4°C.
The plates were incubated at 28°C. After three days, a single colony was visible and was
designated colony A. The plate with colony A was stored at 4°C, and the remaining
electroporation mixture was spread over five more fresh YPDS Zeocin (100mg/L) plates which were
also incubated at 30°C. Three days later, five more colonies had grown on the plates and were
designated B, C, D, E, and F. Colonies were screened by PCR to confirm that they contained the
insert for PGT11.

2.5 – PCR screening of P. pastoris to confirm presence of PGT11 insert
A small bit of each colony A through E was scraped from the YPDS plates with a sterile
pipette tip and re-suspended in 10μL of dH2O in a 200-μL tube. The remainder of each colony
was scraped from the plates with an inoculation loop and inoculated in 5 mL of YPD which was
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incubated for 18 hours at 30°C, 250 rpm. (Note: The colonies were not re-streaked on fresh
plates as they should have been in order to confirm antibiotic selection and ensure the selection
of a single colony.) The cells re-suspended in water were lysed according to the protocol given
by Life Technologies (2011). A 5-μL portion of lyticase (5 U/μL) (lyophilized lyticase powder
from Sigma-Aldrich, SKU 2524) was added to each sample, and the samples were incubated at
30°C for 10 minutes. After incubation, the samples were frozen at -80°C for 10 minutes.
A 1-μL aliquot of cell lysate from each of the six colonies was added to six, 200-μL PCR
tubes. To serve as a positive control, 1μL of PGT11-pPICZ A midiprep DNA isolated from E.
coli (section 2.1) was added to a seventh PCR tube. To serve as a negative control, 1μL of empty
pPICZ A vector midiprep DNA from E. coli was added to an eighth PCR tube. The following
PCR master mix was prepared: 45.2 μL dH2O, 16 μL 5X Green GoTaq™ DNA polymerase
reaction buffer (Promega), 4 μL of 10μM AOX1 5’ primer, 4 μL of 10μM AOX1 3’ primer,
0.8μL of 10mM dNTPs mix (Promega), and 2 μL of GoTaq™ DNA polymerase. Then, 9 μL of
the master mix was added to each of the eight PCR tubes. (Note: Promega recommends only
0.25 μL of GoTaq DNA polymerase per 50-μL reaction, whereas 0.25 μL per 10-μL reaction was
mistakenly used here. Promega recommends that 2 mM of each dNTP, whereas 1 mM of each
dNTP was used here; for screening of P. pastoris transformed with pPICZ A constructs, Life
Technologies (2011) recommends 0.5 mM in each dNTP. Concentration of each primer was
0.5μM and falls within Promega’s suggested range of 0.1 to 1.0μM.)
See Tables 3 and 4 below for the details of PCR cycling and primer information. (All
primers were purchased from Integrated DNA Technologies.) After cycling, the 10-μL reactions
were run on agarose (0.8%) gel as previously described. Glycerol stocks of the positive colonies
were prepared from the overnight cultures by adding 500 μL of sterile 50% glycerol (glycerol
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from Fisher Scientific) to 500μL of culture. The stocks were mixed by vortexing for 5 seconds
and then stored at -80°C.

Step
Initiation
Denaturation
Annealing
Elongation
Final Elongation

Temperature (°C)
94
94
51
72
72

Time (s)
120
30
30
90
300

No. of cycles
1
30
1

Table 3. PCR reaction conditions for confirmation of PGT11 D insert in transformant P. pastoris colonies.

Primer
5’ AOX1
3’ AOX1

Sequence
5’ – GACTGGTTCCAATTGACAAGC – 3’
5’ – GCAAATGGCATTCTGACATCC – 3’

Tm (°C)
54.3
54.8

Table 4. Primers used for PCR screening of PGT11 D-pPICZ A transformants.

2.6 – Test inductions of recombinant PGT11
Pichia pastoris have the ability to use methanol as their sole carbon source in the absence
of carbohydrates; this is accomplished by the oxidation of methanol to formaldehyde by the
enzyme alcohol oxidase (Life Technologies 2011). Because alcohol oxidase has low binding
affinity for molecular oxygen, Pichia compensate by up-regulating production of the enzyme via
the AOX1 promoter, which is activated in the presence of methanol and the absence of
carbohydrates (Life Technologies 2011). The gene of interest is cloned into the pPICZ A vector
at the AOX1 promoter, thus expression of recombinant protein is also up-regulated by treatment
with methanol (Life Technologies 2011).
Inductions were carried out as recommended in Life Technologies (2011), Wamucho
(2012), and Hayford (2012), although the culture was scaled down to a smaller volume. Glycerol
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stock of transformant yeast colony F was inoculated in 5 mL of YPD medium (Appendix A) and
incubated for approximately 18 hours at 30°C, 250 rpm. A 100-μL aliquot of the overnight
culture was used to inoculate 50 mL of BMGY (Appendix A) medium in a 250-mL flask. These
first two cultures were grown to generate the mass of cells required before induction with
methanol.
The second overnight culture was grown approximately 18 hours to A600 = 2.0 and was
harvested by centrifugation at room temperature at 3000 x g for 5 minutes. The pellet was resuspended in 100 mL of BMMY medium (Appendix A) to remove any remaining carbohydrate
from the BMGY or YPD medium. The cells were then centrifuged as before, the supernatant
discarded, and the pellet re-suspended in 200mL of BMMY to an A600 = 1.2.
Two 1-mL samples representative of pre-induction conditions were taken immediately
after re-suspension in the BMMY. The samples were spun in a microcentrifuge for 3 min at
13 000 rpm, and the supernatant was discarded. The pellets were stored at -80°C for later
analysis. Of the remaining culture, 25 mL was poured into a sterile, 250-mL flask which was
incubated at 30°C, 250 rpm for 4 days. Two 1-mL samples were taken at 6, 12, 18, 24, 36, 48,
72, and 96 hours post-induction and processed in the same manner as the pre-induction samples.
In the second and third trials, with colonies A and B, the 96 hour sample collection was omitted.
In order to maintain induction conditions throughout the four-day period, 100% methanol was
added every 24 hours to a final concentration of 0.5%.

2.7 – Extraction of protein from PGT11 D-pPICZ A pre- and post-induction samples
Pre- and post-induction cell pellets were thawed on ice. Approximately 100 μL of acidwashed glass beads (bead diameter = 0.5 mm) (Sigma) were added to each pellet. In the first
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attempt to detect recombinant enzyme (using colony F), 1 mL of breaking buffer (Appendix B)
was mistakenly added to each pellet; in subsequent trials (using colonies A and B), 100 μL of
breaking buffer was added to each pellet.
The cells were lysed by vortexing the samples for 30 seconds at maximum speed and
then cooling them on ice for 30 seconds. Vortexing and cooling steps were repeated for a total of
eight cycles. The lysed cells were then microcentrifuged at 14 000 rpm, 4°C for 10 min. The
supernatant was transferred to a fresh 1.5-mL microfuge tube, and the protein concentration of a
2-μL aliquot of each sample was read on a Nanodrop-1000 spectrophotometer in “Protein A280”
mode, which reads an A280 = 1 as a concentration of 1 mg/mL.

2.8 – SDS-PAGE and staining of protein gels
Attempts were made to detect recombinant PGT11 using three transformant colonies. In
the first attempt to detect recombinant protein, protein samples were more dilute, and 9.9 μg of
each crude protein was analyzed by SDS-PAGE and Western blot. In the latter two trials, less
breaking buffer was used to extract protein, and samples were more concentrated. Thus, a 50-μg
portion of crude protein from each sample was analyzed. Samples were prepared for SDS-PAGE
by adding the appropriate amount of protein, diluting with dH 2O to a volume of 18 μL, then
boiling for 5 minutes with 6 μL of 4X SDS-PAGE Sample Buffer. (Recipes of all stocks,
solutions, and buffers used for SDS-PAGE and Western blot are in Appendix B.)
Protein samples were loaded into a 0.75-mm gel with a 5% acrylamide (pH 6.8) stacking
gel and a 10% acrylamide (pH 8.8) separating gel. The separating gel was prepared by mixing
1.3 mL of 40% acrylamide/bisacrylamide mix (Bio-Rad), 2.3 mL dH2O, 1.3 mL 4X separating
buffer, 50 μL 10% SDS, 2 μL TEMED (Fisher Scientific), and 50 μL of 10% APS (freshly
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prepared from ammonium persulfate powder from Fisher Scientific). APS and TEMED were
added last, and the gel was poured to a level of 2 cm from the top of the gel cassette (Bio-Rad
MiniProtean, 0.75 mm), being careful not to introduce bubbles into the gel. The separating gel
was overlaid with approximately 400 μL of water-saturated n-butanol and allowed 20 minutes to
solidify. The n-butanol overlay was poured off, and residual n-butanol and any non-polymerized
acrylamide was blotted away with filter paper and/or rinsed away with dH 2O. The stacking gel
was prepared by mixing 260 μL of 40% acrylamide/bisacrylamide mix (Bio-Rad), 1.5 mL dH2O,
250 μL 4X stacking buffer, 20 μL 10% SDS, 2 μL TEMED, and 20 μL of 10% APS. APS and
TEMED were added last, and the stacking gel was poured until its level reached the top of the
gel cassette. Immediately, a comb was inserted into the top of the cassette to form fifteen wells,
and the gel was given 20 min to solidify. Electrophoresis was done in 1X Tris-glycine
electrophoresis buffer (Appendix B).
The electrophoresis was run at 80 V for about 15 min until the dye front reached the
separating gel, then the volatage was increased to 100 V (Devaiah, personal communication) and
the gel was run for approximately 90 more minutes until the dye front reached the end of the gel.
In the first attempt to detect recombinant PGT11, duplicate gels were run. The first was stained
in Coomassie blue, while the second was used for a Western blot. Due to low protein
concentrations in the first trial, bands detected with Coomassie blue were very faint. Therefore,
the gel was destained in destaining solution (50:40:10 :: dH2O : methanol : glacial acetic acid)
(methanol and acetic acid from Fisher Scientific) and silver stained with a Silver Stain Plus Kit
(Bio-Rad) according to manufacturer’s directions. In the second and third trials, a single gel was
run and analyzed by Western Blot. Duplicate gels were not run because gels for Western blot
were run first, and, after the Western blots failed to detect expression of recombinant PGT11, a
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frameshift was discovered between the insert and the fusion tag used for detection. Thus, any
further work to detect expression of recombinant protein in these cells lines was abandoned.

2.9 – Western blot analysis for detection of recombinant enzyme
The SDS-PAGE gel was electroblotted in transfer buffer (Appendix B) onto a
nitrocellulose membrane (Thermo Scientific) at 65 V for 1 hour. The membrane was then placed
in blocking solution (5% non-fat milk powder in 1X TBS with 0.02% sodium azide) (non-fat
milk powder from TOPCO Associates, LLC.; sodium azide from Fisher Scientific) for 2 hours at
room temperature with gentle agitation. After blocking, the membrane was incubated in primary
antibody (a 1:2500 dilution of monoclonal mouse anti-c-myc (Sigma-Aldrich) in TBS with
0.02% sodium azide) for 2 hours. This primary antibody binds the c-myc epitope which should
be in the engineered fusion tag of recombinant PGT11. Next, the membrane was washed three
times for 5 min each in 25 mL of TBS without azide. The membrane was then incubated in
secondary antibody (a 1:10 000 dilution of goat anti-mouse IgG-AP (immunoglobin G-alkaline
phospatase conjugate) (Novagen) in TBS without azide) for 2 hours with gentle agitation and
washed three times with TBS as before. Next, the membrane was transferred to 15 mL of
alkaline phosphatase buffer (Appendix B). The alkaline phosphatase substrates NBT and BCIP
were added just before use. Because bands were not detected, the membranes were allowed to
develop for 20 min until background protein bands appeared. The alkaline phosphatase reactions
were stopped by placing the membrane in a mixture of 200 μL 0.5M EDTA, pH = 8.0 and 50 mL
TBS (final concentration of 2 mM EDTA).
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2.10 – Miniprep extraction of PGT11-pPICZ A and PGT11-TOPO DNA for sequencing
Because three attempts to detect recombinant protein by Western Blot were unsuccessful,
the plasmid used to transform P. pastoris was sent for sequencing at the University of Tennessee
Knoxville’s Molecular Biology Resource Facility to check for cloning errors. To obtain plasmid
for sequencing, glycerol stock of two of Anye Wamucho’s colonies, A and D, containing
PGT11-pPICZ A plasmid in E. coli were inoculated into tubes containing 5 mL of Low Salt
LBZeocin (25mg/L) (Appendix A). Recall that DNA from PGT11-pPICZ A colony D was used to
transform P. pastoris.
In addition, three of Anye Wamucho’s E. coli colonies, PGT11-TOPO 1, 2, and 3,
containing PGT11 in the cloning vector pCR®4-TOPO, were each inoculated in 5 mL of
LBAmpicillin (100mg/L) (Appendix A). To avoid ambiguity among sample names, Wamucho’s E. coli
colonies PGT11-TOPO 1, 2, and 3 were re-named PGT11 AN-1–, AN-2–, and AN-3–TOPO,
respectively. The cultures were grown overnight at 37°C, 250 rpm. Duplicate cultures were
prepared, and one DNA sample of each pair was sent for sequencing at the University of
Tennessee’s Molecular Biology Resource Facility. Plasmid DNA was extracted from the cultures
with a Qiaprep Plasmid Miniprep Kit (Qiagen) according to manufacturer’s directions. The
optional step of washing the spin column with 500 μL of PB (binding) buffer was included, and
the DNA was eluted in 50 μL of sterile dH2O.
PGT11-pPICZ A DNA from Anye Wamucho’s E. coli colonies A and D (Wamucho
2012) was sequenced with the following primers: 3’ AOX1, 5’ AOX1, CSP152F, and CSP153R.
(Recall that DNA from colony D had been transformed into yeast.) PGT11-TOPO AN-1, AN-2,
and AN-3 were sequenced with the following primers: T3, T7, CSP152F, and CSP153R. Priming
sites for CSP152F and 153R are within the PGT11 sequence. Information for 5’ and 3’ AOX1
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primers, which are complementary to the pPICZ A vector, was given previously in Table 4. T3
and T7 primers are complementary to the PCR4®-TOPO vector. See additional information for
the sequencing primers in Table 5 below.
Primer
CSP152F
CSP153R
T3
T7

Sequence
5’ – TCT TTG ATT TTA TGG TGC AAA ACA TG – 3’
5’ – TTT TGA GTC TTC TGG CAA AAA GTA T – 3’
5’ – ATT AAC CCT CAC TAA AGG GA – 3’
5’ – TAA TAC GAC TCA CTA TAG GG – 3’

Tm (°C)
53.3
53.3
50.3
47.5

Table 5. Primers used to sequence plasmid DNA after unsuccessful detection of expression of
recombinant PGT11. Information for 5’ and 3’ AOX1 primers is given in Table 4, section 2.5. A 5 μM
solution of CSP primers was prepared and sent with plasmid samples. All other primers were provided
by the sequencing facility.

Sequencing results revealed that each of the colonies PGT11-TOPO AN-1, AN-2, and
AN-3 contained a slightly different variant of the PGT11 sequence (see Results). Clone AN-2
was selected for further work. Wamucho’s PGT11-pPICZ A colony D contained clone AN-1 in
the pPICZ A vector. In addition, a frameshift due to an extra base between the 3’ end of PGT11
D insert and the fusion tag used for detection and purification was discovered.

2.11 – PCR modification to correct 3’ frameshift
To correct the frameshift in the PGT11 insert, attempts were made to insert bases.
Inititally, an attempt was made to insert two bases with the primers described below (Table 6).
Primer

Sequence

3’
5’

CSP154R: 5'- CCT CCG CGG CCT GCG GGC CAT TGC TTG -3'
CSP138F: 5'- CGG GGT ACC GCC ATG GCC ATG AGC AGT CCC CAT G -3'

Predicted
Tm (°C)
72.8
72.4

Table 6. Mutagenic 3’ primer and non-mutagenic 5’ primer used in initial attempt to insert two
bases to correct frameshift. CSP154R was designed to insert two bases. Underlined bases are
complementary to desired insertion.

A 1-μL aliquot of PGT11 AN-2–TOPO miniprep DNA described in section 2.10 was
used as template for the following PCR reaction, designated BW: 10 μL 5x colorless GoTaq
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Buffer (Promega), 1 μL 10mM dNTPs (Promega), 5 μL 10μM CSP138F primer, 5 μL 10μM
CSP154R primer, 27.5 μL sterile dH2O, 1 μL template DNA and 0.5 μL GoTaq DNA
polymerase (5 U/μL) (Promega). (Note: Promega recommends 0.25 μL GoTaq per 50-μL
reaction; however, more was used because it is difficult to pipette this small of a volume.
Promega recommends 2mM of each dNTP; however, 0.2 mM was used here.) PCR conditions
are given in Table 7 below.
Step
Initiation
Denaturation
Annealing
Elongation
Final Elongation

Temperature (°C)
94
94
50
72
72

Time (s)
120
30
30
90
300

No. of cycles
1
30
1

Table 7. PCR conditions for initial attempt to insert two bases to correct frameshift.

2.12 – TA vector cloning of BW PCR product and transformation into TOP10 E. coli
The TOPO TA Cloning Kit for Sequencing (Invitrogen) was used to clone the PCR
product BW into the pCR®4-TOPO cloning vector. A cloning reaction was prepared according to
manufacturer’s directions: 4 μL of the PCR reaction was mixed with 1 μL of supplied salt
solution and 1 μL of TOPO vector. The cloning reaction was incubated at room temperature for
30 min.
Two vials of chemically competent One-Shot TOP10 E. coli were thawed on ice. A 3-μL
aliquot of the cloning reaction was added to a vial of competent cells and gently mixed with the
pipette tip without pipetting up and down. As a positive control, 1 pg of pUC19 DNA was added
to the second vial of competent cells. The cells mixed with transforming DNA were incubated on
ice for 30 minutes after which they were placed in a 42°C water bath for 30 seconds and then
immediately placed on ice for 150 seconds. The vials were then removed from the ice, and
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250 μL of Low Salt LB medium (Appendix A) was added to each. The vials were shaken
horizontally in an incubator-shaker at 37 °C, 225 rpm for 75 min and 75- and 150-μL aliquots
were spread over Low Salt LBAmp (100 mg/L) plates. After 15 hours of growth at 37°C, eight single
colonies were selected from the plate and suspended in 100 μL of water.
A 1-μL aliquot of each cell suspension was used as template for PCR reactions to confirm
the presence of PGT11 in the pCR4 TOPO vector. The following master mix was prepared:
59 μL sterile dH2O, 24 μL 5x Green GoTaq reaction buffer, 2.16 μL 10mM dNTPs, 12 μL
10 μM T3 primer, 12 μL 10μM T7 primer, and 1μL of GoTaq DNA polymerase (5U/μL). [Note:
dNTPs were 0.2 mM each, whereas Promega recommends 2mM. Because of pipetting
limitations, 1 μL of GoTaq was used for 120μL of reaction (0.083μL per 10-μL reaction),
whereas Promega recommends 0.6 μL for the same volume (0.05 μL per 10-μL reaction).] T3
and T7 primers were previously described (Table 5). A 9-μL aliquot of the mix was added to
1 μL of each template and the reactions were cycled as in Table 8 below. After PCR, the
reactions were run alongside 5 μL of exACTGene 1kb plus DNA ladder on agarose 0.8% gel as
described previously.
Step
Initiation
Denaturation
Annealing
Elongation
Final Elongation

Temperature (°C)
94
94
50
72
72

Time (s)
120
30
30
120
300

Table 8. PCR conditions for screening of PGT11 BW-TOPO transformants.
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No. of cycles
1
30
1

2.13 – Restriction of AN-2 insert from PGT11-TOPO BW-1 plasmid and restriction of
pPICZ A vector
One of the eight positive colonies containing the PGT11 AN-2—TOPO plasmid, BW-1,
was selected for further work. It was re-streaked on a fresh Low Salt LBAmp (100mg/L) plate and
incubated at 37°C for 16 hours. A single colony from this plate was inoculated into 5 mL of Low
Salt LBAmp (100mg/L). In addition, E. coli containing empty pPICZ A vector were inoculated from
glycerol stock into 5 mL of Low Salt LBZeocin (25mg/L). These cultures were incubated for 16 hours
at 37°C, 250 rpm. Plasmid DNA was extracted by miniprep as described previously. The
concentration of each sample was measured as before using a Nanodrop-1000
spectrophotometer. The concentration of BW-1 plasmid read over 600 ng/μL, so the
concentration of a 1:20 dilution was read instead: 36.6 ng/μL. The concentration of pPICZ A
plasmid was 175.6 ng/μL. Restriction digestions of the concentrated BW-1 plasmid (732 ng/μL)
and pPICZ A plasmid were set up as in Table 9 below.
Reaction
KpnI
SacII

Plasmid
(μL)
1.37 of 1:10
dilution
1.37 of 1:10
dilution

Plasmid
(μg)

10X buffer A
(μL)

10X BSA dH2O
(μL)
(μL)

0.10

1.00

1.00

0.10

1.00

1.00

KpnI
(μL)

SacII
(μL)

5.6

1.00

---

5.6

---

1.00

KpnI
+
1.37
1.00
2.00
2.00
12.6
1.00
1.00
SacII
pPICZ A
5.69
1.00
2.00
2.00
8.3
1.00
1.00
:Table 9. Restriction digestions of BW-1 PGT11-TOPO and pPICZ A plasmid for ligation.
Buffer A and restrictases were obtained from Promega. 10X BSA was prepared from 100X stock
(Promega).

The reactions were incubated for 2 hours at 37°C after which they were run on agarose
(0.8%) gel as described previously alongside 100 ng of each undigested plasmid. The bands
corresponding to PGT11 insert and digested pPICZ A vector were excised from the gel and
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placed in pre-weighed 1.5-mL microfuge tubes. The DNA was then purified using a Wizard SV
Gel and PCR Clean-up Kit (Promega) according to manufacturer’s directions with one
modification: The DNA was eluted in 30 μL of sterile dH2O rather than 50 μL to increase the
concentration of the samples; according to the kit manufacturer’s manual, elution volume may be
reduced to as little as 15 μL without significantly decreasing yield (Promega 2010). DNA
concentration was measured as previously described using 2-μL aliquots of each sample (Table
10 below).
DNA
PGT11 insert
pPICZ A vector

Concentration (ng/μL)
8.8
16.2

Table 10. Concentrations of BW-1 PGT11 insert and pPICZ A vector following agarose gel
band excision and purification.

2.14 – Ligation of PGT11 AN-2 insert into pPICZ A vector and
transformation into TOP10 E. coli
The following ligation reaction (moles of vector:moles of insert = 1:3) was set up: 7.7 μL
(125 ng) pPICZ A vector, 17.8 μL (157 ng) PGT11 insert, 3μL 10X ligase buffer (Promega), and
1.5 μL T4 DNA ligase (Promega). The reaction was mixed by pipetting and centrifuged at
10 000 rpm for 10 seconds, after which it was incubated at 4°C for 16 hours. A 15-μL aliquot of
the ligation mixture was used to transform TOP10 E. coli as previously described. After recovery
of the cells from heat shock, 75- and 150-μL aliquots of transformation mixture were spread over
Low Salt LBZeocin (25mg/L) plates (Appendix A) which were incubated for 16 hours at 37°C.
Colonies grew too thickly on these plates for selection of single colonies, so 10- and 20-μL
aliquots of transformation mixture were spread over fresh plates. After incubation under the
same conditions, thinly distributed colonies were observed on these two plates. Six were selected
and designated B1 - B6.
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2.15 – Sequencing of B1, B2, and B3 PGT11-pPICZ A DNA
Transformant colonies were PCR screened for presence of the PGT11 insert as described
in section 2.1; however, the colonies were screened with AOX1 primers (Table 4), and reactions
were run as in Table 3. The reactions were run on agarose (0.8%) gel as described previously.
The six positive colonies were each inoculated into 5mL of Low Salt LB Zeocin (25mg/mL) and
incubated overnight at 37°C, 250 rpm. Glycerol stocks were prepared as before and stored at
-80°C. As described before, DNA was extracted by miniprep from the remaining 4.5-mL cultures
of colonies B1, B2, and B3. The DNA samples were shipped with 5μM CSP152F and 153R
primers to the University of Tennessee’s Molecular Biology Resource Facility for sequencing.
Samples were sequenced with 5’ and 3’ AOX1 primers and clone specific primers CSP152F and
CSP153R as described in section 2.10.

2.16– Second attempt to correct 3’ frameshift by PCR site-directed mutagenesis
Because sequencing results showed that none of the plasmid DNA samples contained the
desired insertion of two bases, a second attempt was made to correct the frameshift by inserting
two bases using primers CSP138F and CSP154R. This time, however, the annealing temperature
was increased. This was done to melt secondary structure in the CSP154R primer which may
have interfered with obtaining the desired PCR product. In a second reaction, an attempt was
made to insert eight bases using a newly designed mutagenic primer, CSP155R, whose
secondary structure melted at a much lower temperature than the T m of the primer (Table 11).
A 1:100 dilution was made of PGT11-TOPO AN-2 DNA from the miniprep described in
section 2.10 by mixing 1 μL with 99 μL of water. The dilution was used as template for PCR.
Reaction mixtures used in the modification reactions were (in final concentrations) 1X colorless
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GoTaq reaction buffer, 0.2 mM dNTPs (note that Promega suggests 2 mM), 1 μM in each of two
primers, 0.1 ng template/μL, and 0.08 units GoTaq DNA polymerase/10-μL reaction (note that
Promega recommends 0.05 U/10 μL of reaction). See PCR conditions in Tables 12 and 13
below. A gradient of annealing temperatures was performed with 10-μL PCR reactions. To avoid
secondary structure interference in obtaining the proper PCR product, the PCR products with the
highest annealing temperatures were used for cloning into the pCR4-TOPO TA vector. These
were designated 3M and 4M. CSP155R was less specific to the template DNA, hence the lower
annealing temperature for reaction 3M.

Rxns

Primers

Predicted
Tm (°C)

Hairpin
Tm (°C)

4M

CSP154R: 5'- CCT CCG CGG CCT GCG GGC CAT TGC TTG -3'

72.8

68.4

3M

CSP155R: 5'- ATC CGC GGC CTC CTC CTG CGG GCC ATT GCT TGA T -3'

73.5

55.3

3M and 4M

CSP138F: 5'- CGG GGT ACC GCC ATG GCC ATG AGC AGT CCC CAT G -3'

72.4

44.4

Table 11. Melting temperatures and secondary structure melting temperatures of primers used
in attempts to correct 3’ frameshift by inserting bases. CSP154R and CSP155R are mutagenic 3’
primers. CSP138F was a non-mutagenic 5’ primer used in both reactions 3M and 4M. Underlined
bases in the mutagenic primers are complementary to the desired insertions.

Step
Initiation
Denaturation
Annealing
Elongation
Final Elongation

Temperature (°C)
94
94
See Table 12
72
72

Time (s)
120
30
30
90
300

No. of cycles
1
30
1

Table 12. Conditions for PCR modification reactions.

Reaction
4M
3M

Annealing Temperature (°C)
70
64.5

Primers
CSP138F, CSP154R
CSP138F, CSP155R

Table 13. Annealing temperatures of PCR modification reactions whose products were cloned
into the pCR4-TOPO vector.
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The TOPO TA Cloning Kit for Sequencing (Invitrogen) was used to clone PCR products
3M and 4M into the pCR®4-TOPO cloning vector. Two cloning reactions were prepared
according to manufacturer’s directions: 4 μL of each PCR product was mixed with 1 μL of
supplied salt solution and 1 μL of TOPO vector. The cloning reactions, designated 3M and 4M
after the PCR products, were incubated at room temperature for 30 min.

2.17 - Transformation of PGT11 3M- and PGT11 4M-TOPO into TOP-10 E. coli
The cloning reactions were used to transform TOP10 E. coli as described previously.
Following recovery, 35- and 70-μL aliquots of each transformation mixture was spread over Low
Salt LBAmp (100mg/L). The plates were incubated for 16 hours at 37°C, and eight colonies each of
PGT11 3M-TOPO and PGT11 4M-TOPO were selected. Overnight cultures of the selected
colonies were grown approximately 15 hours at 37°C, 250 rpm in 7 mL of Low Salt LBAmp
(100mg/L).

Glycerol stocks of all 16 colonies were stored at -80 °C, and plasmid DNA was extracted
by miniprep (as described previously) from two 3-mL aliquots of each culture. One DNA sample
of each culture was sent for sequencing with M13 primers (complementary to TOPO vector) at
the University of Tennessee Knoxville’s Molecular Biology Resource Facility. M13 primers are
described in Table 14 below:
Primer
M13 forward
M13 reverse

Sequence
5’ – GTA AAA CGA CGG CCA G – 3’
5’ – CAG GAA ACA GCT ATG AC – 3’

Tm (°C)
50.7
47.0

Table 14. Primers used for sequencing PGT11-TOPO DNA after second attempt to correct
frameshift. These primers were provided by the sequencing facility.
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2.18 - Stratagene QuikChange® Site-Directed Mutagenesis for frameshift correction
Because the foregoing procedures were unsuccessful in correcting the 3’ frameshift by
inserting two or eight bases within the PGT11 sequence, the QuikChange® Lightning SiteDirected Mutagenesis Kit (Stratagene) was used to delete a single base directly from the
PGT11 B2-pPICZ A construct.
E. coli containing PGT11 B2-pPICZ A DNA (see sections 2.12-2.16 for origin of clone
B2) were inoculated into 5 mL of Low Salt LBZeocin (25 mg/L). The culture was incubated 16 hours at
37°C, 250 rpm, and PGT11 B2-pPICZ A plasmid was extracted by miniprep as previously
described. This plasmid DNA was used as the template for a PCR site-directed mutagenesis
reaction using the QuikChange® Lightning Site-Directed Mutagenesis Kit. The following
components were mixed together for a 50-μL PCR reaction mixture (“reaction 1”) in accordance
with manufacturer’s instructions (Agilent Technologies 2007): 37.5 μL sterile milliQ H2O, 1 μL
plasmid DNA from miniprep (44.7 ng), 5μL 10X reaction buffer from the kit, 2μL (125 ng) of
mutagenic primer CSP165F, 2μL (125 ng) of mutagenic primer CSP166R, 1 μL of dNTP mix
from kit, and 1.5 μL QuikSolution™. A second 50-μL mixture (“reaction 2”) was made
similarly, using 1 μL of a 1:3 dilution of miniprep DNA rather than the miniprep DNA stock.
The kit’s manufacturer recommends reactions with template concentrations between 10 and 100
ng per 50-μL reaction (Agilent Technologies 2007). A 1-μL portion of Lightning Enzyme™ was
added to each 50-μL mixture and mixed thoroughly by pipetting. Primer information is given in
Table 15 below. Reactions 1 and 2 were run as described in Table 16.
Primer
CSP165F
CSP166R

Sequence

Tm (°C)

5' - GCA ATG GCC CGC ACC GCG GGG CCG CCA GCT TGG GCC CG - 3'
5' - CGG GCC CAA GCT GGC GGC CCC GCG GTG CGG GCC ATT GC - 3'

81.1

Table 15. Mutagenic primers for correction of 3’ frameshift in PGT11 insert by whole-plasmid mutagenesis.
These primers were purified by PAGE as recommended by the Stratagene kit manufacturers.
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Step
Initiation
Denaturing
Annealing
Elongation
Final Elongation

Temperature (°C)
95
95
60
68
68

Time (s)
120
20
10
141 (30 seconds/kb)
300

No. of cycles
1
18
1

Table 16. Cycling conditions for PCR whole-plasmid mutagenesis using Stratagene QuikChange Lightning SiteDirected Mutagenesis Kit.

Following PCR, 2 μL of DpnI restriction enzyme from the kit, which selectively cleaves
methylated template DNA, was added to each reaction and mixed thoroughly by pippetting. The
reactions were then incubated for 1 hour at 37°C. A 10-μL aliquot of each reaction was run on
0.8% agarose gel stained with ethidium bromide as described previously to confirm proper
amplification. A 4-μL aliquot of each reaction was used to transform TOP10 E. coli (Invitrogen)
as described previously in section 2.12. TOP10 E. coli were used rather than the XL1 Gold
Supercompetent cells supplied with the kit because a prior transformation attempt with the cells
was unsuccessful.

2.19 – Transformation of TOP10 E. coli with PGT11–pPICZ A DNA corrected for 3’
frameshift and selection of ten transformant colonies for PCR screening
Following heat-shock transformation, 250 μL of Low Salt LB medium (Appendix A) was
added to each of the two vials of cells. The vials were then shaken horizontally in an incubatorshaker at 37 °C, 225 rpm for 75 min, after which 50- and 100-μL portions of each transformation
mixture were plated on Low Salt LBZeocin (25mg/L) (Appendix A). The two plates spread with E.
coli transformed with DNA from PCR site-directed mutagenesis reaction 1 were designated 5MC
#1 and #2. Plates spread with E. coli containing DNA from reaction 2 were designated 5MD #1
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and #2. The plates were incubated for 16 hours at 37°C, and five 5MC colonies and five 5MD
colonies were selected. Colonies were designated 5MC-1, 5MC-2, etc. and 5MD-1, 5MD-2, etc.
Each colony was suspended in 100 μL of sterile milliQ water. A 50-μL aliquot of each
cell suspension was inoculated in 7 mL of Low Salt LBZeocin (25mg/L), and the cultures were
incubated approximately 16 hours at 37°C, 250 rpm. Glycerol stocks were prepared from each
culture by mixing 500 μL of sterile 50% glycerol with an equal volume of culture; the glycerol
stocks were stored at -80°C.
Before the cultures were left to incubate overnight, the remaining cell suspension of each
colony was boiled for 5 min to extract DNA for PCR screening to confirm that PGT11-pPICZ A
DNA was within the selected colonies. The following PCR master mix was prepared: 60μL 2X
GoTaq master mix (Promega), 24 μL sterile milliQ H2O, 12 μL 10μM 5’ AOX1 primer, and
12 μL 10μM 3’ AOX1 primer. A 9-μL aliquot of this mix was mixed with 1 μL of each boiled
cell suspension. As a negative control, one 9-μL aliquot of master mix was mixed with 1 μL of
sterile dH2O. The reactions were cycled as previously described (Table 3, section 2.5) and run
on agarose gel as described prevously.
Using a Qiaprep™ Plasmid Miniprep Kit as described previously, plasmid DNA was
extracted from two 3-mL aliquots of each culture. One DNA sample from each colony was sent
for sequencing with 5’ and 3’AOX1 (vector-specific) primers at the University of Tennessee
Molecular Biology Resource Facility.
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2.20 - Confirmation of 3’ frameshift correction
Initial sequencing results revealed that all six colonies contained the deletion to correct
the 3’ frameshift. However, not enough data were received to sequence completely through the
PGT11 insert. Therefore, more DNA was needed for sequencing with internal primers.
To ensure that single colonies were selected, glycerol stocks of colonies 5MC-2, 5MC-3,
and 5MC-4 were each streaked on a Low Salt LBZeocin 25mg/L plate, which was subsequently
incubated 16 hours at 37°C. A single colony was selected from each plate and inoculated into
5 mL of Low Salt LBZeocin, which was incubated for 16 hours at 37°C, 250rpm. Glycerol stocks
of each of the three cultures were prepared as described previously and stored at -80°C. From the
remaining 4.5 mL of each culture, plasmid DNA was extracted by miniprep and sent for
sequencing at the University of Tennessee. Sequencing results confirmed that 5MC-2, 5MC-3,
and 5MC-4 all contained the PGT11 sequence of clone AN-2 in the proper frame with the 3’
fusion tags, and 5MC-2 was selected for further work.

2.21 – Midiprep of PGT11 5MC-2—pPICZ A DNA corrected for 3’ frameshift
Glycerol stock of E. coli containing 5MC-2 DNA was inoculated into 5 mL of Low Salt
LBZeocin (25mg/L) and incubated ~20 hours at 37°C, 250 rpm. A 100-μL aliquot of this culture was
used to inoculate 100 mL of fresh Low Salt LBZeocin (25mg/L), and this second culture was
incubated 16 hours at 37°C, 250 rpm. The culture was divided into two portions and 5MC-2
plasmid DNA was extracted from each using a QuantumPrep™ Plasmid MidiPrep Kit (Bio-Rad)
as described in section 2.1 but with the following modification: Plasmid DNA samples were
eluted in 600 μL of sterile dH2O into 2-mL microfuge tubes.
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The concentrations of the two DNA samples were measured from 2-μL aliquots using a
Nanodrop-1000 spectrophotometer and its accompanying computer software. Concentration
measurements are given in Table 17 below.

DNA

Concentration (ng/μL)

5MC-2 I
5MC-2 II

232.6
197.2

Total DNA in
600-μL sample (μg)
139.6
118.3

Table 17. Concentrations of pPICZ A and PGT11-pPICZ A Plasmid DNA extracted from E. coli.

2.22 – SacI restriction for linearization of PGT11-pPICZ A 5MC-2 DNA
As explained in section 2.2, it is advantageous to linearize pPICZ A constructs by
cleavage at a single restriction site within the AOX1 promoter region before transformation into
Pichia pastoris. The mixture described in Table 18 below was prepared in order to linearize
PGT11 5MC-2—pPICZ A plasmid, which was corrected for the 3’ frameshift between the insert
and fusion tags. All reaction components except for SacI (Promega) were mixed together
thoroughly by pipetting, and SacI was added and mixed gently by pippetting. The mixture was
microfuged at 10 000 rpm for 20 seconds and then incubated at 37°C for 4 hours.

Sample
5MC-2

Plasmid DNA
(μL)
300

Total Mass of DNA
(μg)
69.8

10X Buffer J
(μL)
37.88

10X BSA
(μL)
37.88

SacI
(μL)
3.00

Note: 10X Buffer J is supplied with SacI (Promega). 10X prepared from supplied 100X BSA (Promega.)
Table 18. Reaction mixture of restriction digest for linearization of PGT11-pPICZ A 5MC-2 plasmid.

After 4 hours of incubation, 3 μL more SacI was added to the reaction. The SacI was
mixed with the reaction and centrifuged as before, then returned to 37°C overnight (~12 hours).
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The following morning, a 1-μL aliquot of reaction mixture was diluted 1:5 by mixing it with
4 μL of sterile dH2O. A 1-μL aliquot of undigested 5MC-2 midiprep DNA sample I was diluted
in the same manner. A 1-μL aliquot of each 1:5 dilution was then mixed with 4μL of sterile
dH2O and 1μL of 6X blue/orange dye (Promega). The samples were then run on agarose (0.8%)
gel alongside 5μL of exACTGene 1kb plus DNA ladder (Fisher Scientific). The linearization
reaction appearing complete, the SacI digestion reaction was stopped by heating at 65°C for 15
min.

2.23 - Purification and concentration of linearized PGT11 5MC-2—pPICZ A plasmid
DNA (chloroform-phenol extraction and ethanol precipitation)
To the digestion (linearization) reaction mixture, 400 μL (an equal volume) of phenol:
chloroform: isoamyl alcohol (25:24:1) (Fisher Scientific) was added. Each sample was then
vortexed vigorously for 30 seconds and microcentrifuged for 1 minute at 13 000 rpm. Of the top
(aqueous) phase, 360 μL was drawn off and transferred to a fresh tube, and 36 μL (1/10 volume)
of sterile 3M sodium acetate was added, followed by 990 μL (2.5 volumes) of ice-cold 100%
ethanol. The sample was then inverted several times to mix and then incubated overnight in a
-20°C freezer.
The following morning, the sample was microcentrifuged at 15 000rpm, 4°C for 15
minutes. Unlike with the previous precipitation, an off-white DNA pellet was clearly visible. The
supernatant was carefully decanted, and the DNA pellet was washed in 250 μL of ice-cold 80%
ethanol. The samples were then centrifuged at 15 000rpm, 4°C for 10 min. The supernatant was
carefully decanted, and the DNA pellet was dried by inverting the tube for 15 minutes at room
temperature on a double layer of Kimwipes (Kimberly-Clark). The pellet was then re-suspended
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in 15 μL of sterile dH2O. A 1:20 dilution was made of the concentrated, linearized plasmid DNA
solution by mixing 1 μL with 19 μL of sterile dH2 O. The concentration of the dilution was
determined using a 2-μL aliquot on a Nanodrop-1000 spectrophotometer: 151.5 ± 4.9 ng/μL
(n = 4). Multiplication of the 1:20 dilution’s concentration by 20 showed that the remaining
14 μL of concentrated, linearized plasmid DNA stock contained 3.0 ± 0.1 μg DNA/μL and
sufficient for transformation into in Pichia pastoris.

2.24 – Electroporation of P. pastoris with linearized PGT11 5MC-2—pPICZ A construct
As described previously, yeast cells were grown to the proper growth phase for
electroporation; however, in this second trial, a 50-mL culture was grown to an A600 = 1.3 rather
than 1.4. The competent yeast cells were harvested by centrifugation, but the procedure was
slightly altered: The cells were re-suspended in less 1M sorbitol than the last trial to ensure that
cell density was high enough for a successful electroporation. The Pichia Easy Select Kit user’s
manual recommends re-suspending yeast from a 500 mL culture in 1 mL of 1 M sorbitol in the
final step. Thus, the first trial’s final re-suspension of yeast from 100 mL of culture in 1 mL of
1 M sorbitol was improperly scaled. The cells in this second electroporation would have been resuspended in 100 μL of 1 M sorbitol; however, two workers were sharing the cells for separate
electroporations, and the volume was adjusted to 200 μL to ensure that there would be enough
suspension for both.
The cells were centrifuged at 1500 x g for 3 min at 4°C. The supernatant was discarded,
and the pellet was re-suspended in 50 mL of ice-cold sterile dH2O. The cells were then
centrifuged as before, the supernatant discarded, and the pellet re-suspended in 25 mL of ice-cold
sterile dH2O. The cells were centrifuged as before, the supernatant discarded and the pellet re-
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suspended in 4 mL of ice-cold, sterile 1 M sorbitol (sorbitol powder from Acros Organics). The
cells were then centrifuged one final time, the supernatant discarded and the cells re-suspended
in 200 μL of sterile, ice-cold 1 M sorbitol. This last suspension of cells was transferred to a
sterile 1.5-mL microfuge tube and kept on ice until the electroporation less than 30 min later.
An 80-μL portion of the yeast suspension was mixed with 14 μL of remaining linearized,
concentrated PGT11 5MC-2– pPICZ A DNA, and the mixture was transferred to an
electroporation cuvette on ice (Bio-Rad GenePulser). The cuvette was incubated on ice an
additional five minutes, after which it was pulsed on manual setting at 1.50 kV in a Bio-Rad
MicroPulser™. Immediately after pulsing, 1 mL of ice-cold, sterile 1 M sorbitol was added to
the cuvette. Next, the entire content of the cuvette was transferred to a sterile, 15-mL
polypropylene tube and incubated at 30°C for 90 min without shaking. Following the incubation,
25-, 50-, 100-, and 200-μL aliquots were plated on YPDSZeocin (100mg/L) plates (Appendix A). The
remaining cells were stored at 4°C.
The plates were incubated at 28°C for 72 hours. Over 100 colonies were present on the
four plates after incubation. Twelve colonies were selected and re-streaked on YPDSZeocin (100mg/L)
plates (Appendix A) and incubated at 28°C for 60 hours.

2.25 – PCR screening of P. pastoris colonies transformed with PGT11 expression
construct corrected for frameshift (PGT11 5MC-2—pPICZ A)
A single colony from each of the 12 re-streaked transformant colonies was re-suspended
in 20 μL of sterile dH2O. Half of each yeast suspension was transferred to a new tube and stored
at 4°C. The cells of the remaining 10 μL of suspension were lysed to extract template for PCR
(Life Technolgies 2011): A 5-μL aliquot of lyticase (5 u/μL) (lyophilized powder from Sigma-
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Aldrich) was mixed with each cell suspension and incubated at 30°C for 15 minutes. The cell
suspensions were frozen at -80°C for 10 minutes.
The following PCR master mix was prepared: 85 μL 2X GoTaq master mix (Promega),
17 μL 10 μM CSP138F primer, 17 μL 10 μM CSP139R primer, and 17 μL sterile dH2O. An 8μL aliquot of master mix was mixed with 2 μL of each cell lysate. As a negative control, 2 μL of
sterile dH2O was mixed with 8 μL of master mix. As positive controls, 8-μL aliquots of master
mix and 1 μL of sterile dH2O were mixed with each of the following: 1 μL of a 1:5 dilution of
5MC-2 midiprep DNA, 1 μL of a 1:10 dilution of midiprep, and 1 μL of a 1:20 dilution. Primers
used in the PCR screen were complementary to the ends of the PGT11 insert and are described in
Table 19 below. PCR conditions are given in Table 20.
Primer
CSP 138F
CSP 139R

Sequence

Tm (°C)
72.4
70.4

5’-CGG GGT ACC GCC ATG GCC ATG AGC AGT CCC CAT GTT GTG-3’
5'- CCT CCG CGG TGC GGG CCA TTG CTT G -3'

Table 19. Primers used for PCR screening of PGT11 5MC-2—pPICZ A transformants, designed by
Wamucho (2012).

Step
Initiation
Denaturing
Annealing
Elongation
Final Elongation

Temperature (°C)
95
95
65
72
72

Time (s)
120
30
30
120
300

No. of cycles
1
30
1

Table 20. PCR conditions for screening of PGT11 5MC-2—pPICZ A transformants.

2.26 – Test Inductions of recombinant enzyme in PGT11 5MC-2–p PICZ A transformants
All twelve colonies screened gave PCR product that matched the expected size of
PGT11. Colonies 1 through 4 were re-streaked again to ensure the use of single colonies for test
inductions of recombinant PGT11. The plates were incubated for 48 hours at 28°C, after which a
39

single colony from each plate was inoculated into 30 mL of BMGY medium (Appendix A) in a
125-mL Erlenmeyer flask. The cultures were incubated for 22 hours until they reached the
following absorbance values:
Colony
1
2
3
4

A600
2.21
2.10
1.34
1.79

Table 21. Optical densities of transformant yeast cultures grown in
BMGY to generate biomass for induction.

The colonies were harvested and re-suspended in BMMY as in section 2.6; however, the
cells were washed in only 30 mL of BMMY. After washing, the cells were centrifuged as before
and re-suspended in BMMY to the following A600 values.

Colony
1
2
3
4

A600
1.31
1.22
1.10
1.17

Table 22. Optical densities of transformant yeast cultures
in BMMY at induction time zero.

Two 1-mL samples were taken from each re-suspension in BMMY to represent preinduction conditions. A 50-mL aliquot of each culture was placed in a 250-mL Erlenmeyer flask
and incubated at 30°C for four days, adding 100% methanol to a final concentration of 0.5%
every 24 hours to maintain induction conditions. (See section 2.6 for a discussion of how
methanol induces expression.) Two 1-mL samples were taken at intervals throughout a 96-hour
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time course as described previously. Pre- and post-induction samples were processed as
described in section 2.6 and saved at -80°C for later analysis by SDS-PAGE and Western blot.
Protein was extracted from pre- and post-induction cell pellets as described previously,
using 100 μL of breaking buffer (Appendix B). Dilutions were prepared for each protein sample
by adding 2 μL of sample to 18 μL of breaking buffer. Concentrations were determined as
described previously. A 70-μg portion of 0 to 12 h samples of colonies 1 through 4 and 18 h
samples for colonies 1 and 2 were prepared and loaded into a polyacrylamide gel as described
previously. A duplicate gel was prepared; one gel was stained with Coomassie blue and one was
used for Western blot. Recipes for all solutions and buffers used for SDS-PAGE and Western
blot are in Appendix B.
Western blot was repeated as before (section 2.9) with one modification: between
blocking and primary antibody solutions, the membrane was rinsed for 5 min with TBS
containing 0.02% sodium azide to remove excess milk proteins. The membrane was developed
for approximately 20 seconds in alkaline phosphatase substrate solution before stopping the
reaction with 2mM EDTA. Subsequently, four Western blots of the full 96-hour time course
were done, one for each colony 1 - 4. A 64-μg portion of each induction sample was loaded per
well in all four gels for Western blot. Each gel used for Western blot was duplicated for
Coomassie staining.

2.27 – Scale up of expression of recombinant PGT11 (rPGT11)
Based on the analysis of induction samples, colony 3 at 12 hours was chosen for scale up
of expression. Colony 3 was re-streaked on a YPDZeocin 100mg/L (Appendix A) and incubated at
28°C for 2 days. A single colony was used to inoculate 50 mL of BMGY (Appendix A) in a 250-
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mL flask, and the culture was allowed to grow for 24 hours to A600 = 2.9. The culture was
divided into two samples which were centrifuged for 5 min at room temperature, 3000 x g to
harvest the cells. The cell pellets were each re-suspended in 30 mL of BMMY (Appendix A) to
rinse away carbohydrates that could inhibit induction by the AOX1 promoter. The samples were
centrifuged as before, and the cell pellets were re-suspended in a combined volume of 100 mL of
BMMY.
The A600 was adjusted to 1.08 by pouring off cell suspension and adding pure BMMY to
dilute the cells. When the desired density was reached, the cells were incubated for 12 hours at
28°C, 250rpm. The yeast cells were harvested at the end of incubation by centrifuging for 5 min
at room temperature, 3000 x g. The cells were frozen at -80°C overnight for PGT11 enrichment
the following morning.

2.28 – Extraction, desalting, and enrichment of rPGT11
Each cell pellet was re-suspended in 3 mL of ice-cold breaking buffer (Appendix B) with
5mM βME (Fisher Scientific). Cells were lysed using a French press (4 times at 1250psi
[8600kPa]), and the lysed cells were collected on ice. The lysed cells were centrifiuged for
20 min at 4°C, 13 000 x g. The supernatant was decanted into a fresh tube on ice and the pellet
was discarded.
The protein was desalted at 4°C using a pre-packed PD-10 column which had been
equilibrated with 25 mL of equilibration/wash buffer (Appendix B). A volume of 2.5 mL of
supernatant was added to the column. The first 2.5 mL of flowthrough was discarded. A 3.5-mL
portion of equilibration/wash buffer was added to the column and the next 3.5 mL of eluate was
collected. After eluate collection, the column was equilibrated again by washing with 25 mL of
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equilibration/wash buffer, and another 2.5 mL of crude yeast protein was processed in the same
manner.
The total of 7 mL collected from the PD-10 column was enriched using a TALON IMAC
cobalt resin column with a 4-mL bed volume at 4°C. The column was equilibrated with 40 mL of
equilibration/wash buffer containing 5 mM βME, after which the desalted sample was applied to
the column. The flow rate was slow (approximately 0.3 mL/min or 1 drop every 10 seconds) so
that rPGT11 could bind to the column. The flow through was discarded, and the column was
rinsed with equilibration/wash buffer, collecting 2-mL fractions until the A280 reached zero (ten
fractions labeled W1 – W10). To elute recombinant PGT11, the column was washed with 20 mL
of elution buffer (Appendix B) containing 5 mM βME, collecting ten 2-mL fractions.
Aliquots of 45-μL of each of the IMAC wash and elution fractions were saved for later
analysis by SDS-PAGE and Western blot as described previously; however, 15 μL of each
sample was loaded per well rather than an equal mass of protein. Elution fractions 1 – 5 were
pooled together, and concentrated using a Centricon-30 (Millipore, 30-kDa molecular weight
cutoff). The sample was centrifuged for 10 minutes at 4°C, 4000 x g to reduce its volume to
approximately 500 μL. After re-suspending the sample to a final volume of 2 mL with 50 mM
phosphate buffer (pH=7.5) containing 14 mM βME, the sample was centrifuged as before for an
additional 10 min. After this second centrifugation, the enriched enzyme was again re-suspended
in 50 mM phosphate buffer (pH=7.5) containing 5 mM βME to a final volume of 2 mL, which
was transferred to a 2-mL microcentrifuge tube on ice.
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2.29 – Flavonoid GT activity screening of enriched rPGT11
The method for screening recombinant PGT11 (rPGT11) for flavonoid GT activity was
an adaptation of McIntosh et al (1990). Each reaction contained 50 nmol of flavonoid substrate
dissolved in 5 μL of ethylene glycol monomethylether, 50 μL of 50 mM phosphate buffer
(pH=7.5) (Appendix B) containing 14 mM βME, 10 μL of

14

C-UDP-glucose (20 000 cpm/10μL)

in 50 mM phosphate buffer (stock 14C-UDP-glucose [261 mCi/m mol] was purchased from
ICN), and 10 μL of enriched rPGT11. The reactions were incubated for 5 min at 37°C and were
stopped by adding 15 μL of 6 M HCl and vortexing for 5 seconds. Each reaction was performed
in duplicate. A set of time zero reactions were prepared. These were prepared and incubated in
the same manner as the 5 min reactions, but 15 μL of 6 M HCl was added before the enzyme.
Time zero reactions were also performed in duplicate. After stopping the reactions, the flavonoid
content of each reaction, including any glucoside products, was extracted by adding 250 μL of
ethyl acetate (Fisher Scientific) and vortexing for 15 seconds. A 150-μL aliquot of the ethyl
acetate (top) layer was added to 2 mL of Cyto-Scint scintillation fluid and counted in a Beckman
LS 6500 scintillation counter. The measured cpm incorporated was multiplied by
250μL/150μL = 1.667 to account for counting only 150 μL of the 250 μL of the ethyl acetate
layer.
As a negative control, denatured rPGT11 was used; rPGT11 was denatured by boiling for
5 minutes in a water bath. As a positive control, 60 μL of young Duncan grapefruit leaf extract
was used in place of 10 μL of enzyme and 50 μL of 50mM phosphate buffer. (The grapefruit leaf
extract was prepared by grinding approximately 1 g of young grapefruit leaf tissue in 25 mL of
50 mM phosphate buffer with 14 mM βME.) A second positive control was done by using 50 μL
of grapefruit extract in place of 50 mM phosphate buffer, but 10 μL of rPGT11 was also used.
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This second positive control was done to see any inhibitory effects of the concentrated enzyme
on the reaction. The flavonoid substrates used for the enzyme assay are listed with their
molecular weights and structures in Table 23 below.
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Class of substrate

Name of substrate

Molecular weight
(Mr)

Structure

Naringenin

272.25

CH3

Hesperitin

302.2

Eriodictyol

288.25

Isosakuranetin

286.28

Apigenin

270.25

Luteolin

286.28

Diosmetin

300.26

Scutellarein

286.24

Flavanone

Flavone
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Flavonol

Isoflavone

Kaempferol

286.24

Quercetin

338.3

Fisetin

286.24

Gossypetin

318.14

4’-Methoxyflavonol

268.27

4’-acetoxy-7-hydroxy-6methoxyisoflavone

326.31

Table 23. Flavonoid substrates used for GT activity screening.
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3. Results
3.1 – Attempt to express rPGT11 using PGT11 D-pPICZ A plasmid
PGT11 D-pPICZ A DNA was extracted from Anye Wamucho’s E. coli colony D by
midiprep and linearized by restriction digest with SacI. Figure 4 confirms that the DNA was
sufficiently linearized for purification, concentration, and transformation into Pichia pastoris.
(Non-linearized plasmid would result in multiple bands because linear and circular DNA migrate
differently.) Empty vector was also extracted from E. coli and linearized as a negative control.
Figure 4. Confirmation of linearization of
PGT11 D-pPICZ A DNA with SacI for
electroporation of P. pasotris. Agarose (0.8%)
gel stained with ethidium bromide.

M

PG

PA
4.7kb
3.3kb

M is 10μL of exACTGene 1kb plus DNA ladder.
PG (from left to right, samples PG1 and PG2):
PGT11 D-pPICZ A (PGT11 D insert in pPICZ A
vector).
PA (from left to right, samples PA1 and PA2):
empty pPICZ A vector (no PGT11 D insert).
All PG and PA lanes represent 2-μL aliquots from
each digestion reaction.

Linearized DNA was purified by phenol:chloroform extraction and ethanol precipitation.
Aliquots of 1 and 2 μL of 1:20 dilutions of each concentrated stock were run on agarose gel
alongside exACTGene 1kb plus DNA ladder (Figure 5). The brightness of the band
corresponding to 1 μL of 1:20 dilution appeared much more intense than the 43- and 41-ng bands
of the quantitative DNA ladder exACTGene 1kb plus DNA ladder. Thus, the concentration of
the remaining 9 μL of stock PGT11-pPICZ A DNA was greater than 43 ng/μL x 20 = 860 ng/uL
(>7.74 μg in 9μL) and was deemed sufficient for transformation into P. pastoris; the exact
concentration, however, was not determined. The pPICZ A vector’s user manual recommends 5

48

to 10 μg of linearized DNA in a volume of 5 to 10 μL for transformation (Life Technologies
2011).
M

PG1
PG2
PA1
PA2
Volume of 1:20 dilution: 10μL 1μL 2μL 1μL 2μL 1μL 2μL 1μL 2μL
43ng
4.7kb
41ng
3.3kb

Figure 5. Confirmation of sufficient concentration of linearized PGT11 D-pPICZ A
DNA for transformation of Pichia pastoris. PG1 and 2: pPICZ A with PGT11 insert.
PA1 and 2: pPICZ A (no insert). The band for 1 μL of sample PG2 was compared to the
quantitative marker M (exACTGene 1kb plus DNA ladder).

The concentrated, linearized DNA from sample PG2 was used to transform Pichia
pastoris by electroporation, and six transformant colonies (A through F) were tested for the
presence of PGT11 by PCR screen with AOX1 primers complementary to the pPICZ A vector.
Results showed that PCR reactions using cell lysate as template produced a PCR product of the
expected size for all six colonies (Figure 6); thus, it appeared that all the colonies contained the
PGT11 D-pPICZ A construct within their genome.

Figure 6. PCR screen of P. pastoris colonies transformed with PGT11 D-pPICZ A DNA. M is 10μL
exACTGene 1kb plus DNA ladder. The positive and negative controls (+) and (-) are reactions using
plasmid DNA isolated from E. coli as the template. Positive control used PGT11 D-pPICZ A as template
(1700-bp product = 300bp of vector + 1400bp of PGT11 insert). Negative control used pPICZ A (empty
vector) as template (300-bp product = 300 bp of vector). A through F are PCR reactions using cell lysate
from transformant Pichia colonies A through F as template.
49

Because colonies appeared to contain PGT11-pPICZ A expression construct, expression
of recombinant PGT11 enzyme was induced in BMMY (methanol complex medium). (See
section 2.6 for a discussion of how methanol induces expression.) Western blot analysis of
induction protein samples did not show any expression of recombinant PGT11 protein (Figure
7). Overall protein expression pattern in colony F is shown in Figure 8; before duplicate gels of
A and B were done, a frameshift was discovered which prevented expression of PGT11 in frame
with the fusion tag used for detection.
M

A

0 to 96h post-induction

F

0 to 72h post-induction

M

Figure 7. Western blots of induction time course
of PGT11 D-pPICZ A P. pastoris colonies A, B,
and F. M is Bio-Rad pre-stained low range size
standard. Each sample in A and B contained 50μg
protein; each sample in F contained 9.9μg. Primary
antibody was mouse monoclonal anti-c-myc.
Secondary antibody was goat anti-mouse IgG-AP.
Membranes were developed for over 20 minutes.

B

kDa M

0h

6h

12h 18h 24h 36h

48h 72h 96h

Figure 8. Silver stain of PGT11 D-pPICZ A P.
pastoris colony F induction time course samples.
Expected size of recombinant PGT11 is 55kDa.

97
66
45
31
22
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3.2 – Discovery of a 3’ frameshift in PGT11 D-pPICZA and discovery of PGT11 clones
AN-1, AN-2, and AN-3
Because recombinant PGT11 could not be detected by Western blot using antibodies
against the c-myc epitope, expected in the fusion tags of the recombinant enzyme, the PGT11 DpPICZ A plasmid which had been used to transform P. pastoris was sent for sequencing to check
for cloning errors. Sequencing results revealed a frameshift due to a single extra nucleotide
between the 3’ end of the PGT11 sequence and the sequence of the fusion tag used for detection
by Western blot and purification by ion affinity (Figure 9).

PGT11 D
Corrected

PGT11 D
Corrected

polyhistidine tag
(purification)

c-myc epitope
(detection)

Figure 9. Alignment of frameshifted PGT11 D sequence and a corrected sequence from
which one nucleotide has been deleted. The base highlighted in red was the one deleted using
whole-plasmid PCR site-directed mutagenesis.

Subsequent sequencing of Anye Wamucho’s (Wamucho 2012) modified PGT11 clones
in the pCR®4-TOPO cloning vector revealed three different clones, all of which varied slightly
from the harvEST database PGT11 contig sequence and with each other (Tables 24 and 25).
These three clones were designated PGT11 AN-1, PGT11 AN-2, and PGT11 AN-3. Comparison
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of PGT11 D-pPICZ A and the PGT11 AN-TOPO clones confirmed that Wamucho (2012) cloned
AN-1 into pPICZ A for expression in yeast. Of the three clones, AN-2 had the fewest amino acid
differences with the translation of the PGT11 contig sequence from the harvEST database
(Mallampalli 2009) and was selected for cloning into the pPICZ A vector and correction of the 3’
frameshift in order to express recombinant enzyme in yeast.
Nucleotide – Position
in harvEST PGT11
contig sequence
G–311

AN-1 (PGT11 D)

AN-2 (PGT11 5MC-2)

AN-3

A

A

A

A–581

G

G

G

G–647

same

A

A–939
A–940
A–941

same

T–942
G–943

same

deleted

A–944

G

T–945
G–946

same

C–947
T–1018

G

G

G

G–1187

A

A

A

Table 24. Comparison of the DNA sequences of clones AN-1, AN-2, and AN-3 to the harvEST
database contig sequence of PGT11. Underlined nucleotide codes are differences common to all three
AN clones. AN-1 matches the Wamucho (2012)’s PGT11 clone D in pPICZ A. AN-2 was selected for
further work.
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PGT11 (harvEST)

AN-1 (PGT11 D)

AN-2 (PGT11 5MC-2)

AN-3

G104

E

E

E

Q194

R

R

R

C216

same

same

Y

same

same

same

G

same

same

N314
D315

deleted

A316
F340

V

V

V

R396

K

K

K

Table 25. Comparison of translations of clones AN-1, AN-2, and AN-3 to a translation of the
harvEST database PGT11 contig sequence. Underlined amino acid codes are differences common to
all three AN clones.

3.3 – Cloning of PGT11 AN-2 into the pPICZ A vector for expression in yeast and attempt
to correct 3’ frameshift by PCR modification
PGT11 was amplified from the AN-2–TOPO plasmid with mutagenic primers in an
attempt to insert two bases at the 3’ end of the PGT11. The presumptively modified PGT11
product was TA cloned into the pCR®4-TOPO vector, and the resultant plasmid (designated
BW) was transformed into TOP10 E. coli. Plasmid DNA was isolated from transformant colony
BW-1 by miniprep. A 1-μg sample of BW-1 plasmid and an equal mass of pPICZ A DNA was
cut with KpnI and SacII restriction enzymes. The appropriate DNA fragments (1.3-kb PGT11
band and 3.3-kb pPICZ A band) were gel purified and ligated together (Figure 10). The resultant
plasmid was transformed into TOP10 E. coli.
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pPICZ A

PGT11 BW-1–TOPO

KpnI
and
SacII

KpnI
Undg KpnI SacII and
SacII

Undg

3.3kb

1.4kb

DNA
per lane:

100 ng

1μg

100 ng

54

Figure 10. Digestions of BW-1–TOPO and pPICZ A
plasmid DNA for ligation of AN-2 insert into
pPICZA. Bands outlined with black boxes were gelpurified and ligated together to insert the PGT11
AN-2 clone into the pPICZ A vector. Undg:
undigested plasmid. KpnI: plasmid digested with KpnI
enzyme. SacII: plasmid digested with SacII enzyme.
KpnI and SacII: plasmid digested with both enzymes.

Plasmid DNA isolated from transformants by miniprep was sent for sequencing.
Sequencing results showed that none of the plasmid DNA samples contained the expected twobase insertion for repair of the frameshift (Figure 11); however, the sequencing results did show
that clone PGT11 AN-2 was now within pPICZ A. The frameshift in one of these plasmids,
PGT11 B2-pPICZ A, would later be repaired by deletion of a single base using whole-plasmid,
PCR site-directed mutagenesis.

Figure 11. Alignment of plasmid PGT11 B2-pPICZ A sequence and its predicted sequence.
Alignment shows only the 3’ end of the PGT11 insert and the fusion tag sequence. The two base pairs
highlighted in red are the expected insertion.

3.4 – Attempt to correct 3’ frameshift by PCR modification to insert bases
In a second attempt to correct the frameshift, a new 3’ mutagenic primer (CSP155R) was
designed to insert eight bases. It was thought that secondary structure of the primers could be
interfering with obtaining the desired PCR product. Therefore, a gradient of annealing
temperatures were used, and the products formed with the highest annealing temperatures were
used because secondary structure was more likely to be melted. In addition, the primer
previously designed to insert two bases (CSP154R) was used in separate reactions with higher
annealing temperatures than attempted before.
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The PCR products were cloned into pCR®4-TOPO, and the resultant PGT11-TOPO
plasmids were transformed into TOP10 E. coli. Sequencing of plasmid DNA isolated from
transformant colonies, however, revealed that insertions of neither two nor eight bases had been
incorporated into the PCR products (data not shown).

3.5 - Correction of 3’ frameshift by whole-plasmid site-directed mutagenesis
Because previous attempts to correct the 3’ frameshift in PGT11 by insertion of bases
were unsuccessful, additional mutagenic primers were designed. These primers and a
QuikChange Lightning Site-Directed Mutagenesis Kit (Stratagene) were used to delete a single
base. Having generated mutant plasmid by PCR, the methylated template was digested using
DpnI, and the remaining mutant plasmid was transformed into TOP10 E. coli. Sequencing of
plasmid isolated from transformant colonies 5MC-2, 5MC-3, and 5MC-4 confirmed that the
frameshift was corrected as depicted previously in Figure 9 and in Figure 12 on the following
page.
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A

B

Figure 12. Alignment of PGT 11-pPICZ A 5MC-2 sequencing data with PGT 11 sequence from harvEST
database. A: 5’ alignment. B: 3’ alignment. One-letter amino acid translations are given below each DNA
sequence. Gray highlights: KpnI (5’) and SacII (3’) restriction sites. Green: yeast consensus sequence.
Turquoise: PGT11 sequence. Pink: c-myc epitope. Yellow: polyhistidine tag. Restriction sites and yeast
consensus sequence were added to the ends of PGT11 by Wamucho (2012).

3.6 – Test inductions of recombinant PGT11 (5MC-2), SDS-PAGE, and Western blot
analysis
Recombinant PGT11 was induced by culturing four colonies of Pichia pastoris
containing the expression vector with PGT11 insert in the methanol complex medium BMMY.
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Cell pellet samples were collected over a time course of four days. Crude protein was extracted
from the cell pellets, and 75μg of each protein sample was run on a 10% polyacrylamide gel. An
equal amount of protein was loaded for each sample so that the Western blot could show a semiquantitative comparison of expression levels. The Western blot was performed with antibodies
against the c-myc epitope in the C-terminal fusion tag and developed in an alkaline NBT/BCIP
substrate solution (Figure 13). From the results of the preliminary Western blot, colony 3
appeared to have the highest expression of any colony at any of the time points represented, and
colony 1 appeared to have the lowest expression of the 12 h samples.
kDa
97
66
45

0h

6h

18h

12h

55kDa
Colony: 1

2

3

4

1

2

3

4

1

2

31
22

14

Figure 13. Preliminary Western blot of PGT11 5MC-2 Pichia colony induction samples. Membrane was
developed under 20 seconds.

The Western blot was repeated with fresh protein extract (66μg of each sample) (Figure
14 below). All induction samples (0 to 96h) were run over a total of four Western blots. Samples
of colonies 1 and 3 at 12h were included on all the blots in order to determine relative levels of
expression between them. Blots 1 and 2 show that colony 3 at 12 hours had higher expression
than colony 1 and 2 at any other time point. Blot 3 shows that colony 3 had the highest levels of
expression from 12 to 48h. Blot 4 shows that colony 4 had the highest levels of expression from
12 to 48h, and colony 4 at 12 h appears to have higher expression than colony 3 at 12 h.
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Although this disagrees with the result of the preliminary Western blot (Figure 13), which
showed higher expression for colony 3 at 12 h, detection is only semi-quantitative. Based on
these results, colony 3 at 12h was chosen for scale-up of expression of recombinant PGT11.
Duplicate gels stained with Coomassie blue show the overall protein expression pattern during
induction (Figure 15); it is difficult to distinguish rPGT11 (55kDa) from proteins of similar
molecular weight.
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Figure 14. Western blots of full 96-hour time courses for colonies 1
through 4. The 12-hour samples from colonies 1 and 3 were included on
all four blots to determine relative levels of expression between them.
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Figure 15. Coomassie stained duplicates of gels used for Western
blot analysis of induction samples.

3.7 – Scale-up of expression and enrichment of recombinant PGT11
Expression of rPGT11 was scaled up to a 100-mL culture which was harvested 12 hours
after induction with methanol. Protein was extracted by French press, desalted, enriched by
cobalt IMAC, and concentrated and dialyzed by centrifugal filtration with a 30-kDa filter. After
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the activity screening, aliquots of washes, elutions, and enriched enzyme were analyzed to
confirm that the proper elution fractions were concentrated for activity screening (Figure 16). It
was confirmed that the fractions containing the most rPGT11 had been pooled and concentrated
for flavonoid GT activity screening.
E6-E10
W1

W2 W3 E1 E2 E3 E4 E5

Z
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W1 - W3
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Z

97
66
45
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22

14

Figure 16. Enrichment of rPGT11 by IMAC. A: Coomassie-stained
SDS-PAGE; arrow indicates rPGT11. B: Western blot with antibodies
against the c-myc epitope. W1 – W3: The first three of ten 2-mL wash
fractions of impure proteins; A280 in the final wash was 0.0. E1 – E10:
Ten 2-mL elutions of enriched rPGT11 with 150 mM imidazole.
Z: pooled, dialyzed, and concentrated fractions E1-E5.
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3.8 – GT activity screening
The enriched rPGT11 was screened for GT activity by measuring incorporation of
14

C-glucose from 14C-UPD-glucose (sugar donor substrate) into the products of reactions with

flavonoid substrates. Little to no activity was detected with any of the substrates screened (Table
26). Two substrates showed high average incorporation but had inconsistent duplicates. These
should be tested again.
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Class of
Substrate

Structure

Name of Substrate

cpm
cpm
incorporated incorporated
0 min (n=2)
5 min (n=2)
(avg ±SD)
(avg ±SD)

Net cpm
incorporated
(5min – 0min)

Naringenin
4’=5=7=OH

180 (2)

182 (21)

2

Hesperetin
3’=5=7=OH, 4’=OCH3

163 (5)

165 (64)

2

Eriodictyol
3’=4’=5=7=OH

172 (26)

163 (25)

-9

Isosakuranetin
5=7=OH, 4’=OCH3

191 (46)

193 (25)

2

Apigenin
4’=5=7=OH

155 (5)

184 (46)

29

Luteolin
3’=4’=5=7=OH

183 (8)

164 (18)

-18

Diosmetin
3’=5=7=OH, 4’=OCH3

166 (58)

162 (26)

-4

Scutallerein
4’=5=6=7=OH

141 (4)

163 (14)

23

CH3

Flavanone

Flavone
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Flavonol

Isoflavone

Kaempferol
5=7=4’=OH

157 (2)

157 (31)

0

Quercetin
3’=4’=5=7=OH

213 (6)

188 (18)

-25

Fisetin
4’=5’=7=OH

176 (34)

138 (37)

-38

Gossypetin
3’=4’=5=7=8=OH

163 (47)

1202 (1424)

1038

4’-Methoxyflavonol
4’=OCH3

221 (58)

173 (11)

-48

4’-acetoxy-7-hydroxy6-methoxy isoflavone

188 (28)

2554 (3358)

2366

Table 26. Flavonoid GT activity screening results. Each reaction contained 20 000 cpm and was performed in
duplicate. Results printed in red had inconsistent duplicates and should be repeated. Reactions were incubated at
37°C for 5 min.

Two positive controls were done, one with young grapefruit leaf extract as a flavonoid
glucosyltransferase source and one with both grapefruit leaf extract and enriched rPGT11. Low
activity was observed with the grapefruit leaf extract alone; however, the control including both
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grapefruit extract and rPGT11 had higher activity than rPGT11 with any of the substrates
screened (Table 27).

Control
Grapefruit
Extract
+
Quercetin
Grapefruit
Extract
+
Quercetin
+
rPGT11

cpm incorporated (0 min)
(n=2)
(Avg ± S.D.)

cpm incorporated (5 min)
(n=2)
(Avg ± S.D.)

Net cpm
incorporated
(5min – 0min)

295 (52)

82

331 (13)

118

205 (40)

-8

213 (6)

Boiled rPGT11

Table 27. Flavonoid GT activity screening control reactions. Each reaction contained 20 000 cpm and was
performed in duplicate. Reactions were incubated at 37°C for 5 min.
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4. Discussion
4.1 – Attempt to express rPGT11 using the PGT11 D-pPICZ A construct
PGT11 was mined from the harvEST database and identified as a putative secondary
product glucosyltransferase based on the presence of the PSPG box consensus motif
(Mallampalli 2009) (Figure 3). Mallampalli (2009) amplified the gene from grapefruit cDNA
and cloned it into the pCR4-TOPO vector. Subsequently, Wamucho (2012) cloned PGT11 into
the pPICZ A vector for expression in yeast.
In this work, Wamucho’s PGT11-pPICZ A construct was isolated from his E. coli colony
D. The PGT11 D-pPICZ A DNA was linearized by SacI digestion (Figure 4), purified by
phenol-chloroform extraction, concentrated by ethanol precipitation (Figure 5), and transformed
into P. pastoris by electroporation (Figure 6). All colonies screened with primers
complementary to vector sequence on either side of the PGT11 insert gave PCR products of the
expected size; a frameshift in the sequence due to a single extra base pair (as was later
discovered) is not detectable in PCR products of this size.
Attempts were made to induce expression of recombinant PGT11 (rPGT11) with
methanol under control of the Pichia AOX1 promoter; however, expression was not detected by
Western blot (Figure 7). When expression was not detected, PGT11 D-pPICZ A plasmid which
had been used to transform P. pastoris was sent for sequencing to check for cloning errors. A
frameshift was discovered between the 3’ end of the PGT11 insert and the sequence of the fusion
tags used for detection and purification (Figure 9); it is likely that recombinant PGT11 was
expressed but was not detected because the sequence of the tag used for detection was out of
frame with the PGT11 gene sequence.
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4.2 – Discovery of three distinct PGT11 clones (AN-1, AN-2, and AN-3)
After discovery of the frameshift, other PGT11 clones (AN-1, AN-2, and AN-3) in the
PCR4-TOPO vector were sent for sequencing. All three clones differed slightly with each other
and with the harvEST database PGT11 contig (Tables 24 and 25). The differences among the
clones may result from varying paralogs, isoforms, and/or polymorphisms of PGT11 in
grapefruit. Grapefruit is a hybrid of species, and polyploid genetics may further complicate this
issue. Differences between the AN clones and the harvEST database contig sequence are not
surprising, as the database contains ESTs from multiple Citrus species. AN-2, which had the
fewest amino acid differences with the harvEST database contig, was selected for further work.

4.3 – Correction of 3’ frameshift
The frameshift at the 3’ end of the PGT11 insert was common to all three AN clones. In
an effort to correct the frameshift by insertion of two or eight bases, the AN-2 insert was
amplified from AN-2—TOPO plasmid DNA with mutagenic primers. The PCR products were
cloned into pCR4-TOPO and transformed into E. coli. Sequencing results of DNA isolated from
transformant colonies showed that the desired bases were not inserted. It is possible that template
plasmid DNA, which was not destroyed or removed from the PCR mixture, was transformed
with greater efficiency than the plasmid containing the cloned PCR product. Secondary structure
complications of the mutagenic primers may have prevented amplification of the desired PCR
product as well.
Initially, clone AN-2 had been successfully cloned into the pPICZ A vector; however it
still contained a frameshift at its 3’ end. To correct the frameshift, a Stratagene QuikChange Kit
was used to delete a single base between the 3’ end of the insert and the fusion tag sequence, and
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sequencing results confirmed proper cloning and successful deletion of the single base (Figures
9 and 10). It is notable that the mutagenesis kit uses DpnI restriction enzyme to selectively
destroy template DNA before transformation into E.coli. The lack of DpnI digestion may
account for the previous unsuccessful mutagenesis attempts, because both the wild-type template
(plasmid without the desired mutation) and mutant plasmid were present in the DNA used for
transformation of E.coli.

4.4 – Expression of rPGT11 protein in P. pastoris using a PGT11-pPICZ A construct
corrected for frameshift
PGT11-pPICZ A construct corrected for the 3’ frameshift was transformed into P.
pastoris and expression of rPGT11 was induced with methanol. Cell pellets of the induction
cultures of four transformant colonies were collected over a 96-hour time course. An equal
amount of protein from each induction cell pellet was analyzed by SDS-PAGE and Western blot.
The Western blot with antibodies against the c-myc epitope showed sustained expression of
rPGT11 in colonies 3 and 4 from 12 to 48 hours after induction, with the highest expression at 12
hours after induction (Figures 13 and 14). Colony 3 at 12 hours was chosen for scale-up of
expression.

4.5 – Enrichment of rPGT11and flavonoid GT activity screening
The bulk of rPGT11 eluted from IMAC was within the fractions concentrated and used
for activity screening; however, in future work, rPGT11 may be further enriched by using lower
concentrations of imidazole to remove more proteins before washing with higher concentrations
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of imidazole to elute tightly bound rPGT11 (Figure 15). The enriched rPGT11 was screened for
activity with flavonoid substrates (Tables 26 and 27).
The substrates gossypetin and 4’-acetoxy-7-hydroxy-6-methoxy isoflavone showed high
incorporation of 14C-glucose, which could indicate GT activity; however, the activity is not
statistically significant because incorporation varied from low to high in duplicate reactions
using these substrates. Such discrepancies between duplicates are often due to errors in
extraction of products from the reaction mixture (McIntosh, personal communication). In the
process of extraction, ethyl acetate is added to the reaction mixture and mixed by vortexing. All
of the flavonoid content, including any glucoside products with incorporated 14C, is dissolved in
the ethyl acetate layer. A portion of the upper ethyl acetate layer is removed for scintillation
counting. Inadvertently drawing up any of the lower aqueous layer containing unused 14C-UDPglucose can greatly inflate readings. This could account for observing such wide variation
between duplicate tests with gossypetin and 4’-acetoxy-7-hydroxy-6-methoxy isoflavone; however,
the substrates should be re-tested before GT activity is ruled out.

4.6 – Directions for future research
Although no significant flavonoid GT activity of rPGT11 was detected, the hypothesis
that PGT11 is a secondary product GT is not yet disproved. Because of the instability of
glucosyltransferases, the long purification time may have influenced the results (Owens and
McIntosh 2011). In future work, screening should be repeated for confirmation, especially for
those substrates for which incorporation of 14C varied from low to high between duplicates; such
repetition could determine if either the low or high duplicate reading was a statistical outlier.
Although counts for the positive control reactions using young grapefruit leaf extract were low, it
is interesting that the positive control which contained both grapefruit extract and rPGT11
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showed higher activity than any of the substrates tested. The rPGT11 could be using a compound
within the extract as its substrate. If this effect is reproducible, future work could determine
which substrates are present in the extract.
In addition to repetition of the work done here, future work could screen additional
subclasses of flavonoids for activity. Flavonoids unrepresented here include chalcones,
anthocyanidins, and dihydroflavonols. Berhow et al (1998) collected data on the phenolic content
of Citrus species, and additional potential substrates could be chosen from aglycones for which
glucosides exist in grapefruit. If no activity is found with any flavonoid substrates, simple
phenolics and phenolic acids, such as those tested by Hayford (2012) and Wamucho (2012)
could be tested. Triterpenoids such as limonoate A-ring monolactone are potential substrates as
well (Hasegawa et al 1997). Future work could also test PGT11without a fusion tag to see if this
has any effect on the activity. If any activity is found with PGT11 clone AN-2, then AN-1 and
AN-3 could be tested, as well as the Citrus senensis homolog with over 80% identity and 90%
similarity (orange1.1g012744m, www.phytozome.net).
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Appendix A: Growth media recipes and associated stock solutions
All chemicals and materials in this section were purchased from Fisher Scientific.

1M potassium phosphate buffer (200 mL)
4.60 g dibasic potassium phosphate
23.63 g monobasic potassium phosphate
Dissolve the above in ~150 mL dH2O. Adjust to pH = 6.0 with potassium or phosphoric acid;
allow to return to room temperature before final pH adjustment. Bring volume to 200 mL with
dH2O. Autoclave for 20 min on liquid cycle.

10X GY (10% glycerol) (500 mL)
Dissolve 50 mL of glycerol in 450 mL dH2O for a final volume of 500mL. Autoclave 20 min on
liquid cycle.

10X M (5% methanol) (500 mL)
Mix 25 mL of methanol with 475 mL dH2O for a final volume of 500 mL. Filter sterilize.

10X YNB (200 mL)
6.80 g yeast nitrogen base (without ammonium sulfate and amino acids)
20 g ammonium sulfate
Heat gently but do not boil to dissolve the above in ~150 mL dH2O. Add dH2O to 200 mL. Filter
sterilize.

78

500X B
Dissolve 20 mg biotin in 100 mL dH2O and filter sterilize. Store at 4°C.

Ampicillin (100 mg/mL) stock solution
~100 mg ampicillin sodium powder
~1 mL sterile dH2O
Into a 1.5-mL microfuge tube, weigh ~100 mg of ampicillin powder. Add 1000μL of
dH2O per 100 mg of ampicillin. Vortex or shake the microfuge tube until the powder is dissolved
in dH2O. (Note: Solution was not filter sterilized as it should have been.) Store 200-μL aliquots
at -20°C.

BMGY or BMMY medium for growth of Pichia pastoris (1 L)
10 g yeast extract
20 g peptone
100 mL 1 M potassium phosphate buffer (pH=6.0)
100 mL 10X YNB
100 mL 10X G or 100mL 10X M
2 mL 500X B
Dissolve yeast extract and peptone in a final volume of 700 mL of dH2O. Autoclave 20 min on
liquid cycle. Cool to RT, then (for BMGY) add phosphate buffer, 10X YNB, 10X G and 500X
B. Mix well and store at 4°C. For BMMY, add 10X M instead of 10X G.
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LBAmp (100mg/L) growth medium for Escherichia coli (400mL)
2 g yeast extract (0.5%)
4 g tryptone (1%)
4 g sodium chloride (1%)
For LB plates: 6g agar (1.5%)
Dissolve yeast extract, tryptone, and sodium chloride in ~300 mL of dH2O. Adjust to pH=7.5
with NaOH, then add dH2O to a final volume of 400 mL. Add agar to autoclave bottle or flask
just before sterilizing. Autoclave 20 min on liquid cycle and cool to room temperature. Cool
medium to ~60°C and add 400 μL of Ampicllin (100 mg/mL) stock solution.

Low Salt LB growth medium for Escherichia coli (400mL):
2 g yeast extract (0.5%)
4 g tryptone (1%)
2 g sodium chloride (0.5%)
For Low Salt LB plates: 6 g agar (1.5%)
Dissolve yeast extract, tryptone, and sodium chloride in ~300 mL of dH2O. Adjust to pH=7.5
with NaOH, then add dH2O to a final volume of 400 mL. (For plates, add agar to autoclave bottle
just before sterilizing.) Autoclave 20 min on liquid cycle and allow to cool to room temperature.
For Low Salt LBZeocin (25mg/L) plates, cool plates to ~60°C before adding 100 μL of Zeocin™
(100 mg/mL) stock solution. For Low Salt LBamp (100mg/L) plates, cool medium to ~60°C and add
400 μL of Ampicllin (100 mg/mL) stock solution.
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YPD growth medium for P. pastoris (400 mL):
4 g yeast extract (1%)
8 g peptone (2%)
For YPD plates: 8g agar (2%)
40 mL of 20 % dextrose (final concentration of 2%)
Filter-sterilize or autoclave 20 % dextrose (prepared from D-α-glucose powder) solution for
20 min on liquid cycle; cool to room temperature. Dissolve peptone and yeast extract in
~300 mL of dH2O, then add dH2O to a final volume of 360 mL. Autoclave 20 min on liquid
cycle and allow to cool to room temperature. Add 40 mL of filter-sterilized 20% dextrose to
yeast extract and peptone solution, and swirl to mix. For YPDZeocin (100mg/L) plates, cool solution to
~60°C before adding dextrose and 400μL of Zeocin™ (100mg/mL) stock solution (Appendix B).

Zeocin™ (100mg/mL) stock solution
~100mg Zeocin™ powder (Research Products International)
~1mL sterile dH2O
Into a 1.5-mL microfuge tube, weigh ~100mg of Zeocin™ powder. Add 1000 μL of dH2O per
100 mg of Zeocin™. Vortex or shake the microfuge tube until the powder is dissolved in dH 2O.
(Note: Solution was not filter sterilized as it should have been.) Store 200-μL aliquots at -20°C.
Zeocin is sensitive to light and heat. Keep in the dark when not in use (Life Technologies 2011).
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Appendix B: Recipes for other buffers and solutions
All chemicals and materials in this section were purchased from Fisher Scientific.

10X Transfer buffer
30.3 g Tris base
144.1 g glycine
Dissolve the above in ~900 mL of dH2O. Dilute to final volume of 1L. Prepare 1X transfer
buffer by mixing 100 mL of 10X stock with 700 mL of dH2O and 200 mL of methanol; add
water first to avoid precipitation of Tris and glycine.

4X Separating buffer
18.17 g Tris base
Dissolve Tris base in 80 mL dH2O. Adjust pH to 8.8 with HCl. Allow to cool to room
temperature before final pH adjustment.

4X SDS-PAGE Sample Buffer (Wamucho 2012)
2 mL 1M Tris base (pH = 6.9)
2 mL 20% SDS (soium lauryl sulfate powder)
4 mL 50% glycerol
0.2 mg bromophenol blue
To every 1 mL of above mixture, add 50 μL βME before use.
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4X Stacking buffer
12.11 g Tris base
Dissolve Tris base in 80 mL dH2O. Adjust pH to 6.8 with HCl. Allow to cool to room
temperature before final pH adjustment.

5X TBS buffer (Sambrook et al (1989), pg. B.7)
40 g NaCl
1.00 g KCl
15 g Tris base
Dissolve the above ingredients in 800 mL dH2O, and adjust pH with HCl to 7.4. Allow solution
to cool to room temperature before final pH adjustment. Bring up volume to 1 L with dH2O.
5X Tris-glycine electrophoresis buffer (Sambrook et al 1989) (1 L)
15.1 g Tris base
94 g glycine
Dissolve the above in 800 mL. Bring up volume to 950 mL with dH2O, and add 50 mL of a 10%
SDS solution (prepared from sodium lauryl sulfate powder).

50 mM sodium phosphate buffer (pH=7.5) (1 L)
0.292 g monobasic sodium phosphate
0.773 g dibasic sodium phosphate
Dissolve the above in 900 mL of water. Adjust to pH = 7.5 with potassium hydroxide or
phosphoric acid, and bring up the volume to 1000 mL with dH2O.
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50X TAE buffer for DNA electrophoresis (1 L) (Sambrook et al. 1989)
242 g Tris base
57.1 mL glacial acetic acid
100 mL 0.5M EDTA (pH=8.0)
Dissolve all ingredients in ~700 mL of dH2O, then bring up volume to 1 L with additional dH2O.
Store at room temperature. To make 1X working solution, mix 20 mL of 50X stock and 980 mL
of dH2O.

Alkaline Phosphatase Buffer (200 mL)
1.17 g NaCl
203 mg MgCl2 • 6H2O
2.42 g Tris base
Dissolve the above in 175 mL dH2O. Adjust pH to 9.5 with HCl, and bring up volume to
200 mL. Add 60 μL each of nitro BT (0.083 g/mL in 70% N,N-dimethylformamide) and BCIP
(0.042 mg/mL in 100% N,N-dimethylformamide) within 5 minutes of use.

Breaking buffer (200 mL)
1.38 g monobasic sodium phosphate monohydrate
58 mg EDTA (non-salt)
10 mL glycerol
Dissolve the above in ~150 mL dH2O. Add 10 μL of 0.1M PMSF per mL of breaking buffer just
before use. For purification of proteins, add βME to a final concentration of 5 mM.
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EDTA (0.5 M), pH=8.0 (500 mL)
73.06 g of ethylenediaminetetraacetic acid (EDTA) powder (non-salt)
Mix EDTA and 200 mL of dH2O; EDTA will not completely dissolve. Add 6 M NaOH to the
water and EDTA slowly, monitoring the pH. The EDTA will dissolve as the pH rises.

Elution buffer (IMAC) (1L)
0.292 g monobasic sodium phosphate
0.773 g dibasic sodium phosphate
17.53 g sodium chloride
10.21 g imidizole
Dissolve the above in 900 mL of water. Adjust to pH = 7.5 with potassium hydroxide or
phosphoric acid, and bring up the volume to 1000 mL with dH2O.

Equilibration/wash buffer (pH=7.5) (1 L)
0.292 g monobasic sodium phosphate
0.773 g dibasic sodium phosphate
17.53 g sodium chloride
Dissolve the above in 900 mL of water. Adjust to pH = 7.5 with potassium hydroxide or
phosphoric acid, and bring up the volume to 1000 mL with dH2O.
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MES buffer (pH=5.0)
3.90 g 2-(N-morpholino)ethanesulfonic acid (MES)
Dissolve above in 900 mL dH2O, and adjust to pH=5.0. Add dH2O to 1000 mL.
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